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ABSTRACT 
 
Ever since World War II, antibiotics have been medicine’s number one asset in fighting 
microbial infection, one of the leading causes of death worldwide. Misuse of antibiotics has, 
however, led to rapid spread of antibiotic resistance among bacteria and ensuing development of 
multiple resistant pathogens. Therefore, antibiotics are rapidly losing their antimicrobial value, 
which can be seen a failure of society to protect one of its valuable resources. 
The use of antibiotics in food production animals is strictly controlled by the European Union. 
Veterinary use is regulated to prevent spreading of resistance due to unwarranted use and to 
prevent antibiotic residues in food products. EU legislation establishes maximum residue limits 
(MRLs) of veterinary medicinal products in foodstuffs of animal origin, and enforces countries 
to establish and execute a national monitoring plan of animal products to implement food control 
measures. Among samples selected for monitoring, suspect noncompliant samples are screened 
for and then subjected to confirmatory analysis to establish the identity and concentration of the 
contaminant. Screening methods for antibiotic residues are typically based on microbiological 
growth inhibition, whereas physico-chemical methods are used for confirmatory analysis.  
In this study, antibiotic whole-cell biosensor assays were examined as a novel screening method. 
Utilizing a tetracycline-specific bioluminescent whole-cell biosensor, a screening method for 
tetracycline residues in poultry meat was developed. Assay sensitization to meet the EU MRLs 
was achieved by improving tetracycline accumulation into the biosensor cells with a combination 
of membrane-permeabilizing agent polymyxin B and chelating agent EDTA. The result was a 
rapid, simple and cost-effective high-throughput screening method that could detect all four 
veterinary relevant tetracyclines and their 4-epimer metabolites in poultry meat with sensitivity 
below the MRLs. The study also provided proof of antimicrobial activity of tetracycline 4-
epimer metabolites, a quality previously thought absent from 4-epidoxycycline. 
Nisin is a lantibiotic, a peptide antibiotic produced by lactococci. The industrial use of nisin as a 
food preservative (E234) and maximum allowed levels set by the EU warrant developing 
methods for nisin quantification in foods. In this study, a bioluminescent whole-cell biosensor 
for nisin was constructed and utilized in determining nisin concentrations in milk. The developed 
assay was rapid and simple to perform, and required no sample pretreatment except dilution. 
Sensitivity of the assay was in the sub-picogram per ml level, exceeding the performance of all 
previously published methods. The assay was also used in determining nisin-production 
efficiency by quantifying nisin in growth medium of a nisin-producing Lactococcus strain. 
Simultaneously, nisin producers could be distinguished from non-producers. This idea was 
expanded in a follow-up study, which utilized the nisin biosensor in screening for nisin 
producers in raw milk. Screening was based on simple overlay of raw milk cultures and 
identification of nisin producers by a bioluminescent zone surrounding the nisinogenic colony. 
The seven identified nisinogenic colonies were divided in three groups by genetic fingerprinting, 
II 
 
and characterized as nisin variant Z producing Lactococcus lactis subsp. lactis. In addition, four 
nisin A producers were identified in a panel of 91 dairy lactococcal strains. Specificity studies 
showed that only nisin and not other bacteriocin peptides induced bioluminescence in the sensor 
strain. Also, all nisin-gene harboring colonies induced bioluminescence, with the exception of 
one lactococcal strain shown to carry a nonfunctional nisin gene.  
The development of novel inducible whole-cell biosensors for different groups of antimicrobials 
can be limited by the lack of regulatory elements specifically responsive for these substances. In 
this study, we characterized DNA and ligand binding of the macrolide antibiotic-responsive 
repressor protein, MphR(E). The protein was modified by rational design of mutations to 
improve DNA affinity and dimerization. DNA and ligand binding as well as macrolide-induced 
dissociation from DNA were studied by fluorescence anisotropy and mass spectrometry. Mutants 
with improved DNA affinity and retained ligand binding and dissociation characteristics were 
identified. One mutant surprisingly formed a covalent dimer through disulfide bridge formation. 
This was shown to improve DNA affinity, but ligand binding and induction was impaired. 
Ligand binding spectrum of MphR(E) was shown to cover macrolides with a 14-membered 
lactone ring structure, but macrolides with a 16-membered ring or lincosamides showed no 
binding. MphR(E) and its mutants showed interesting novel characteristics that could benefit 
biosensor design.  
In conclusion, this study shows the applicability of whole-cell biosensors in developing simple, 
robust and cost-effective screening methods for antimicrobials in food products. These methods 
show high sensitivity and specificity towards the target analyte, and can be used in semi-
quantitative to quantative analysis. In addition to residue monitoring, whole-cell biosensors can 
be used for producer identification. The identified nisin producers can find use as protective 
starter cultures in fermented food production. The modified repressor MphR(E) shows promise 
as an improved regulator of reporter gene production in whole-cell biosensor applications, and is 
an example of purposeful effort to develop regulatory elements for novel biosensor designs.  
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TIIVISTELMÄ 
 
Antibiootit ovat olleet tärkein bakteeri-infektioiden hoitokeino aina toisesta maailmansodasta 
lähtien. Bakteeri-infektiot ovat maailmanlaajuisten kuolemansyytilastojen kärkisijoilla. 
Antibioottien huolimaton käyttö on kuitenkin johtanut antibioottiresistenssin nopeaan 
leviämiseen bakteerien keskuudessa sekä useille antibiooteille resistenttien patogeenien 
kehittymiseen. Tämän vuoksi antibiootit menettävät nopeasti antimikrobiaalista voimakkuuttaan, 
mitä voidaan pitää yhteiskunnan kyvyttömyytenä suojella arvokasta pääomaansa. 
Euroopan Unioni valvoo antibioottien käyttöä eläimissä, joita hyödynnetään elintarvikkeiden 
tuotannossa. Eläinlääketieteellistä käyttöä säädellään resistenssin leviämisen ja ruoassa 
esiintyvien antibioottijäämien estämiseksi. EU:n lainsäädäntö osoittaa enimmäisjäämärajat 
eläinlääkinnällisille aineille eläinperäisissä elintarvikkeissa ja velvoittaa jäsenvaltiot laatimaan ja 
toteuttamaan eläimistä saatavien elintarvikkeiden kansallisen vierasainevalvontaohjelman. 
Valvontaan valittujen näytteiden joukosta seulotaan näytteet, joiden epäillään sisältävän jäämiä, 
joiden luonne ja pitoisuus varmistetaan lisäanalyysillä. Seulonnassa käytetään tavallisesti 
mikrobiologiseen kasvuinhibitioon perustuvia menetelmiä, ja varmistukseen fysikaalis-
kemiallisia analyysejä. 
Tässä tutkimuksessa tarkasteltiin kokosolubioantureilla tehtävien antibioottimääritysten 
soveltuvuutta antibioottijäämien seulontamenetelmäksi. Tetrasykliinispesifistä bioluminoivaa 
kokosolubiosensoria käyttäen kehitettiin seulontamenetelmä tetrasykliinijäämien tunnistamiseksi 
kananlihasta. Määritys saatiin herkistettyä EU:n enimmäisjäämärajojen tasolle helpottamalla 
tetrasykliinien pääsyä bioanturisoluun solukalvon läpäisykykyä lisäävällä polymyksiini B:llä 
sekä kahdenarvoisia kationeja kelatoivalla EDTA:lla. Tuloksena oli nopea, yksinkertainen ja 
kustannustehokas seulontamenetelmä, jolla oli korkea suoritusteho. Menetelmä kykeni 
havaitsemaan kaikki neljä eläinlääketieteessä käytettävää tetrasykliiniä sekä niiden 4-epimeeri 
aineenvaihduntatuotteet kananlihassa enimmäisjäämärajat alittavissa pitoisuuksissa. Tutkimus 
myös tuotti todisteita tetrasykliinien 4-epimeerien antimikrobiaalisesta aktiivisuudesta, joka 
aiemmin arveltiin puuttuvan 4-epidoksisykliiniltä. 
Nisiini on laktokokkien tuottama lantibiootti eli peptidiantibiootti. Nisiinin käyttö 
elintarviketeollisuudessa säilöntäaineena (E234) sekä EU:n nisiinille asettama sallittu 
enimmäismäärä elintarvikkeissa luovat tarpeen nisiinin määritysmenetelmille. Tässä 
tutkimuksessa rakennettiin bioluminoiva nisiinispesifinen kokosolubioanturi, jota käytettiin 
määrittämään nisiinipitoisuuksia maidossa. Kehitetty määritys oli nopea ja yksinkertainen, eikä 
vaatinut laimennusta monimutkaisempaa näytteen esikäsittelyä. Määrityksen herkkyys oli alle 
pg/ml mittaluokassa, ja se oli herkin koskaan julkaistu nisiinimääritys. Määritystä käytettiin 
myös nisiinintuotannon tehokkuuden arvioinnissa mittaamalla nisiinipitoisuus sitä tuottavan 
Lactococcus lactis -kannan kasvumediumista. Samanaikaisesti nisiinintuottaja voitiin erottaa 
nisiiniä tuottamattomista kannoista. Tätä ajatusta tarkasteltiin laajemmin jatkotutkimuksessa, 
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jossa nisiinibioanturia käytettiin seulomaan nisiinintuottajakantoja raakamaidosta. 
Yksinkertainen seulontamenetelmä perustui raakamaitobakteerien viljelmien peittämiseen 
ohuella bioanturikerroksella, jolloin nisiinintuottajapesäkkeiden ympärille muodostui biolumine-
senssivyöhyke. Seitsemän tunnistettua nisiinintuottajapesäkettä jakautuivat geneettisen sormen-
jäljen perusteella kolmeen ryhmään, ja ne olivat kaikki Lactococcus lactis subsp. lactis -alalajiin 
kuuluvia nisiini Z -variantin tuottajia. Lisäksi 91 laktokokkikannan paneelista tunnistettin kolme 
nisiini A -variantin tuottajaa. Spesifisyystutkimukset osoittivat, että vain nisiini indusoi 
bioluminesenssin bioanturibakteerissa eivätkä muut bakteriosiinipeptidit. Lisäksi kaikki 
nisiinigeeniä kantavat pesäkkeet indusoivat bioluminesenssin. Poikkeuksena oli yksi 
laktokokkikanta, jonka todettiin kantavan toimimatonta nisiinigeeniä. 
Tietyille antibioottiryhmille spesifisen vasteen antavien säätelyelementtien puute saattaa 
vaikeuttaa kokosolubioanturien kehittämistä. Tässä tutkimuksessa karakterisoitiin 
makrolidispesifisen repressoriproteiini MphR(E):n DNA- ja ligandinsitomisominaisuuksia. 
Proteiinia muokattiin rationaalisen mutaatiosuunnittelun keinoin tarkoituksena tuottaa DNA- ja 
dimerisoitumisominaisuuksiltaan parempia mutantteja. DNA- ja ligandisitoutumista sekä 
makrolidiligandien indusoimaa dissosiaatiota DNA:sta tutkittiin fluoresenssianisotropialla ja 
massaspektrometrialla. Tutkimuksessa löydettiin mutantteja, joilla oli villityypin proteiinia 
parempi DNA-affiniteetti sekä ennallaan säilynyt kyky sitoa ligandeja ja indusoitua sitomisen 
vaikutuksesta. Yksi mutanteista muodosti rikkisillan avulla kovalenttisen dimeerin vastoin 
odotuksia. Kovalentti dimerisaatio paransi DNA-affiniteettia, mutta haittasi ligandin sitomista 
sekä induktiota. MphR(E):n ligandikirjo kattoi 14-jäsenisen laktonirenkaan makrolidit, mutta ei 
16-jäsenisen renkaan makrolideja eikä linkosamideja. MphR(E) ja sen mutantit osoittivat 
mielenkiintoisia uusia ominaisuuksia, jotka voivat hyödyttää bioantureiden suunnittelua. 
Johtopäätöksenä voidaan sanoa, että tämä tutkimus osoittaa kokosolubioanturien soveltuvan 
yksinkertaisten, luotettavien ja kustannustehokkaiden seulontamenetelmien kehittämiseen 
antibioottijäämien osoittamiseen elintarvikkeista. Nämä menetelmät osoittavat suurta herkkyyttä 
ja spesifisyyttä analyyttimolekyyliä kohtaan, ja niitä voidaan käyttää semikvantitatiiviseen sekä 
kvantitatiiviseen analysiin. Jäämien havainnoinnin lisäksi bioantureita voidaan käyttää 
antimikrobiaalisten aineiden tuottajien tunnistamiseen. MphR(E)-mutantit ovat lupaavia 
paranneltua säätelykykyä osoittavia reportterigeenin tuoton repressoreita käytettäväksi 
bioanturisovelluksissa. Ne ovat myös esimerkki rationaalisesta säätelyelementtien parantelusta 
uusien bioanturisovellusten kehittämiseksi. 
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1 INTRODUCTION 
 
Microbes are a double-edged sword to the mankind. Man has harnessed microbes for use in areas 
like food production, bioremediation and manufacturing valuable substances. On the other hand, 
microbial pathogens cause infection in humans, food animals and crops alike. One of the most 
important missions of human and veterinary medicine is defeating these microbial diseases. 
Simultaneously, medicine benefits from microorganisms as probiotics and in the form of 
molecules like drugs, vaccines and antibodies discovered and/or produced in microbes. 
Antibiotics are one such group of medicinal substances, originally produced by and discovered in 
microbes, and then utilized by men in an attempt to overcome microbial infection. 
The widespread and often excessive use of antibiotics in health care and agriculture has led to the 
appearance of resistant pathogens. This is surmised to lead to an emergence of novel perilous 
infections and a revival of diseases that were already considered beaten. Antibiotic resistance is a 
common phenomenon that has evolved simultaneously with the capacity to produce antibiotics, 
dating back millions of years. However, due to human activity, the fraction of resistant 
organisms has risen above normal during the last seven decades (Martinez 2009). The problem 
of increasing resistance has been taken into account by international organizations and 
governments which have devised guidelines for antibiotic stewardship in both veterinary and 
human medicine. However, there still are many countries where the use of antimicrobials is 
controlled laxly or not at all.  Resistant strains originating from these regions can stymie efforts 
in countries attempting to control their own antibiotic use.  
EU legislation enforces countries to establish a national monitoring plan, under which a set 
percentage of animal products is monitored for antibiotic and other residues using screening and 
confirmatory methods of predetermined quality (EC 1996, 2002b). Microbial growth inhibition 
tests are currently the most commonly used screening method for antibiotic residues in food. 
These methods, however, have sensitivity and specificity problems which can lead to false 
negative results.  
This study concentrates on a novel screening method, antimicrobial residue assays based on 
inducible bioluminescent whole-cell biosensors. These biosensors are living bacterial cells which 
have been genetically engineered to produce bioluminescence in the presence of the analyte, the 
antimicrobial agent. Whole-cell biosensors are an affordable screening method, which can offer 
sensitive and specific analyte recognition. The recognition element in the biosensor is typically a 
regulatory protein which recognizes the analyte and induces signal production. This study also 
examines the structure-function properties of a recently discovered regulatory protein and 
modifies it for improved biosensor performance. Biosensor assays are also applicable in 
recognition of novel antimicrobial agents, modes of action, and producer strains. This study uses 
whole-cell biosensors for rapid and specific identification of antimicrobial-producing bacteria.   
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2 ANTIMICROBIAL AGENTS 
 
“The dose makes the poison”, a statement made famous by the renaissance physicist and scientist 
Paracelsus, is still a basic principle of toxicology. In the context of antimicrobial agents, the 
same principle means that an antimicrobial effect is a quality possessed by any substance. 
Bacteria are well-known for their adaptability to any kind of conditions: living bacteria can be 
found in almost any corner of the world, from the deep sea to arid deserts. However, too much 
(or little) of anything will kill them. As an example, curing with salt, pickling with vinegar and 
drying with heat are used in food preservation to create conditions of high ionic strength, low pH 
and little moisture to inhibit bacterial growth. 
Physical (heat, pressure, radiation) as well as chemical agents have antimicrobial activity. 
Antimicrobial agents (also known as antimicrobial substances or antimicrobials) can be defined 
as “natural or synthetic chemical compounds that kill or inhibit the growth of microorganisms” 
(Madigan and Martinko 2006). Examples of these are substances we encounter in our daily life 
such as ethanol, hydrogen peroxide and iodine-containing compounds used as topical antiseptics 
and chlorine, ozone and copper sulfate used for water disinfection.  
Microbes produce a vast number of antimicrobial agents for use as signaling molecules that 
shape the structure of microbial communities and to outcompete organisms occupying the same 
ecological niche (Romero et al. 2011). The hormesis theory is a synthesis of these two effects: 
antibiotics are beneficial to bacteria at low concentrations found in most ecosystems and harmful 
in high concentrations used for therapy (Martinez 2009). Humans have adopted some of these 
substances for use as antimicrobial drugs and preservatives to inhibit bacterial disease and food 
spoilage. The following chapters introduce more closely two groups of antimicrobial agents that 
include the biosensor target analytes of this study. The first is antibiotics, an extremely important 
group of antimicrobials used in human and animal medicinal therapy. The second one is 
bacteriocins, and more exactly nisin, a lantibiotic bacteriocin widely used as a food preservative. 
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2.1 Antibiotics 
 
Antibiotics are one of the most well-known and well-used groups of antimicrobial agents and the 
number one asset of medicine in fighting microbial infection. They represent 46% of sales of all 
anti-infective agents, and a total of 5% of the entire global pharmaceutical market (Hamad 2010). 
A textbook definition for antibiotics is “natural rather than synthetic antimicrobial compounds 
(that are) produced by a wide range of fungi and bacteria and inhibit or kill other 
microorganisms” (Madigan and Martinko 2006, p. 685).  
The busiest time in antibiotic discovery commenced after World War II, when within ten years, 
most of the antibiotic classes still in clinical use were discovered (Table 2.1.). The “Golden Age” 
that began with discovery of novel natural antibiotic classes (1950-1960) and continued with 
development of semisynthetic antibiotics, modified derivatives of natural antibiotics, lasted until 
the 1980’s. This era produced numerous improvements to antibiotic potency and ability to avoid 
resistance through chemical modification of existing antibiotic scaffolds. The number of 
naturally occurring antibiotics increased from ~30 known in 1945 to 150 in 1949, 450 in 1953, 
1200 in 1960, 10000 by 1990 and ~16.500 by 2002 (Borders 2007). However, only around 150 
of these were used in veterinary and ~100 in human therapy in 2002 (Bérdy 2005). 
To overcome resistance mechanisms, development of synthetic antibiotics becomes more 
important as the discovery of new natural antibiotic classes is declining (Clark et al. 2011). 
Despite the effectiveness of novel methods for development of synthetic antibiotics (Clark et al. 
2011, Sun et al. 2011), biosynthetic and fermentative approaches remain the most cost-effective 
methods for large-scale production of antibiotics (Khosla and Tang 2005). Engineered 
biosynthesis pathways must be therefore be developed on basis of known biosynthesis pathways 
of natural antibiotics, making industrial scale production of these novel molecules less 
straightforward (Pickens and Tang 2009, 2010, Wang et al. 2011).  
Like any antimicrobial agent, antibiotics can have a bacteriostatic or bactericidal effect. 
Bacteriostatic agents inhibit bacterial reproduction without affecting viability, whereas 
bactericidal agents kill their target. The major classes of antibiotics with bactericidal effects are 
-lactams, aminoglycosides and quinolones, whereas the remaining classes mainly have 
bacteriostatic effects (Kohanski et al. 2010b). Antibiotic-mediated cell death only begins with 
the primary effect of antibiotic-target interaction (see Table 2.1.). An oxidative damage cellular 
death pathway has been identified as a common secondary mechanism for cell death induced by 
bactericidal antibiotics (Kohanski et al. 2010b). Table 2.1 presents some of the most important 
antibiotic classes and their modes of action. Among these are protein synthesis inhibitors 
tetracyclines as well as macrolide, lincosamide, and streptogramin (MLS) class antibiotics that 
are more closely introduced in the following chapters. These two antibiotic classes are the target 
analytes of biosensor development in this study.  
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Table 2.1. Antibiotics classified according to the Anatomical Therapeutic Chemical Classification 
System with Defined Daily Doses (ATC/DDD) by the World Health Organization (WHOCC 2011).  
Antibiotic class Year of discovery Mode of action Representative members Ref 
Tetracyclines 
J01A* 
1948 (Chlortetracycline) Protein synthesis inhibitors. 
Inhibition of aa-tRNA binding. 
Tetracycline 
Oxytetracycline 
Chlortetracycline 
Doxycycline 
[2] 
 
 
 
Amphenicols 
J01B 
1947 (Chloramphenicol) Protein synthesis inhibitors.  
Blocking of peptidyl transferase 
activity of the ribosome. 
Chloramphenicol 
Thiamfenicol 
[2] 
 
β-lactam 
antibacterials: 
penicillins 
J01C 
1928 (Benzylpenicillin) Cell wall synthesis inhibitors. 
Inhibition of the transpeptidation 
reaction during peptidoglycan 
formation. 
Benzylpenicillin 
Ampicillin 
Methicillin 
Cloxacillin 
[2] 
 
 
Other β-lactam 
antibacterials 
J01D 
1948 (Cephalosporin C) 
1984 (Aztreonam, 
monobactam) 
1985 (Imipenem, 
carbapenem) 
Cell wall synthesis inhibitors. 
Inhibition of the transpeptidation 
reaction during peptidoglycan 
formation. 
Cephalosporins 
Monobactams 
Carbapenems 
[1], [2] 
 
 
Sulfonamides and 
trimethoprim 
J01E 
1935 (Sulfonamido-
chrysoidine) 
Bacterial metabolism interference. 
Inhibition of synthesis of DNA 
precursors. 
Trimethoprim 
Sulfonamides 
 
[3] 
 
Macrolides, 
lincosamides and 
streptogramins 
J01F 
1952 (Erythromycin) 
1963 (Lincomycin) 
19xx (Streptogramin) 
Protein synthesis inhibitors.  
Blocking access of peptidyl-tRNA to 
the ribosome  elongation reaction 
inhibition  dissociation of peptidyl-
tRNA. 
Erythromycin 
Tylosin 
Lincomycin 
Clindamycin 
Pristinamycin 
[1], [2] 
 
 
Aminoglycoside 
antibacterials 
J01G 
1944 (Streptomycin) 
1963 (Gentamicin) 
Protein synthesis inhibitors. 
promotion of tRNA mismatching  
protein mistranslation and premature 
termination. 
Streptomycins 
Neomycin 
Kanamycin 
Gentamicin 
[2] 
 
 
Quinolone 
antibacterials 
J01M 
1960 (Nalidixic acid) 
1978 (Fluoroquinolones) 
DNA replication inhibitors. 
Prevention of DNA strand rejoining 
by topoisomerases (DNA gyrase and 
topoisomerase IV). 
Quinolones 
   Nalidixic acid 
   Flumequin 
Fluoroquinolones 
   Enrofloxacin 
   Difloxacin 
[2] 
 
 
 
Other antibacterials 
J01X 
1939 (Tyrothricin) 
1956 (Vancomycin) 
1961 (Fusidic acid) 
Various mechanisms Glycopeptide antibacterials 
      Vancomycin 
Lipopeptide antibacterials 
      Daptomycin 
Imidazole derivatives 
      Metronidazole 
Pleuromutilins 
      Tiamulin 
Polymyxins 
      Tyrothricin 
      Colistin 
      Polymyxin B 
Steroid antibacterials 
      Fusidic acid 
      Rifampicin 
Ketolide antibacterials 
      Telithromycin 
      Cethromycin 
[1] 
 
 
 
 
 
 
 
 
 
 
 
 
 
*ATC/DDD classification code. [1] Borders 2007, [2] Kohanski et al. 2010b, [3] Stokstad and Jukes 1987. 
.  
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2.1.1 Tetracycline antibiotics 
 
The first member of the tetracycline (TC) group (Figure 2.1A), chlortetracycline, was described 
in 1948 under the name aureomycin (Duggar 1948). From then on, numerous novel TCs were 
discovered (1
st
 generation 1948–1963) or synthesized (2nd generation 1965–1972: semisynthetic 
TCs), and the group rapidly increased in size until the beginning of the 1970s (Chopra and 
Roberts 2001). The first 3
rd
 generation semisynthetic member to the TC family, tigecycline (Fig. 
2.1C), was introduced in 1993 (Testa et al. 1993). It is a derivative of the TC group member 
minocycline, but since it is not affected by some of the key resistance mechanisms to TCs, it has 
also been given a first-in-class status in a new antibiotic class, glycylcyclines (Pankey 2005). 
Recently, two novel classes of tetracycline analogs, pentacyclines (Sun et al. 2011) and 8-
azatetracyclines (Clark et al. 2011), were introduced. Both classes consist of fully synthetic 
molecules, and represent 4
th
 generation tetracyclines.  
The first studies conducted on tetracyclines showed they are broad-spectrum antibiotics affecting 
both gram-positive and gram-negative bacteria (Paine et al. 1948). They exert their bacteriostatic 
antimicrobial activity by inhibiting protein biosynthesis. TC molecules bind the high affinity 
TET1 site on the 30S ribosomal subunit (Aleksandrov and Simonson 2008a). TET1 is located on 
the 16S rRNA, lying right above the ribosomal A site, the binding site of aminoacyl-tRNA 
(Brodersen et al. 2000). Therefore, TCs inhibit translation by allosteric blocking of aa-tRNA 
binding. Binding to other sites such as translation elongation factor EF-Tu and a low affinity site 
TET5 on the 30S subunit has been suggested, but it does not occur in significant amounts under 
physiological conditions (Aleksandrov and Simonson 2008a, 2008b).  
In both cytoplasm and outside the cell, TC exists in equilibrium between a neutral form and a 
charged Mg
2+
-tetracycline chelate. This phenomenon plays an important role in TC antibiotic 
activity and its inhibition as only the chelate can bind TET1 or resistance protein expression-
controlling repressor protein TetR (Lederer et al. 1995, Aleksandrov and Simonson 2008a). On 
the other hand, entry into the cell requires a dissociation step: the chelate passes the outer 
membrane through porins, but only the metal-free form can diffuse through the cytoplasmic 
membrane (Schnappinger and Hillen 1996). Therefore, the intra- and extracellular concentration 
of Mg
2+
 ions is of utmost importance to effectiveness of TC action. 
In addition to bacteriostatic action, several non-antimicrobial effects of tetracyclines have been 
discovered. TCs have long been applied in treatment of dermatological conditions such as 
rosacea or acne, where overexpression of cellular pathways can be affected by TCs (Monk et al. 
2011). The TC doxycycline (DC) has been found to be effective in prevention and treatment of 
malaria (Tan et al. 2011). It interferes with protein synthesis, DNA replication and transcription 
in the organelles apicoplasts and mitochondria of the malaria-causing parasite Plasmodium 
falciparum (Briolant et al. 2010).  
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The non-antimicrobial effects of tetracyclines are typically organ protective. For instance, 
tetracyclines inhibit the function of matrix metalloproteinases (MMPs), scavenge reactive 
oxygen species and show anti-apoptotic as well as anti-inflammatory effects (Griffin et al. 2011). 
These effects together with TCs’ ability to accumulate at tissue-injury sites have led to clinical 
trials to explore their possible beneficial effects in a wide variety of diseases (Griffin et al. 2010). 
Especially chemically modified tetracyclines (CMTs) show promise in treatment of non-
microbial disease. These tetracycline analogs have been stripped of their antimicrobial activity 
by removing the 4-dimethylamino group but they still retain their organ protective effects 
(Griffin et al. 2011). CMTs show promise in treatment of advanced cancers, where they inhibit 
tumor cell proliferation and, unlike in normal cells, induce apoptosis (Lokeshwar 2011).  
Tetracyclines are the most commonly used class of veterinary antibiotics: in a recent study 
covering 10 European countries, tetracyclines accounted for 48% of total sales of veterinary 
antibacterial agents in 2007 (Grave et al. 2010). The WHO (2009) ranking of antimicrobials 
important for human medicine gives tetracyclines a status as critically important antibiotics in 
the three-class system of critically important, highly important and important antimicrobials. 
Tetracyclines as well as other antimicrobials deemed critically important should be prioritized 
for most urgent development of risk management strategies in order to preserve their 
effectiveness in human medicine. 
 
  
7 
 
 
 
 
 
 
Generic name Trade name R1 R2 R3 R4 
Chlortetracycline Aureomycin Cl CH3 OH H 
Oxytetracycline Terramycin H CH3 OH OH 
Tetracycline Achromycin H CH3 OH H 
Demethylchlortetracycline 
(Demeclocycline) 
Declomycin Cl H OH H 
Methacycline* Rondomycin H CH2 OH 
Doxycycline* Vibramycin H CH3 H OH 
Minocycline* Minocin N(CH3)2 H H H 
 
O OHOH
CONH2
OH
N(CH3)2
O
N(CH3)2
OH
NH
NH
O
CH3
CH3
CH3
 
 
Figure 2.1. Chemical structure of tetracyclines. A) General structure for TCs and detailed structures of 
some representative members of the group. B) A bottom view of the chlortetracycline molecule shows the 
characteristic kink in the non-planar four-ring structure with carbons 1 - 3 above the plane. C) Structure of 
tigecycline. 3D-structure of chlortetracycline was taken from Orth et al. 1998, PDB file 1BJ0. 
*Semisynthetic molecules. 
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2.1.2 Macrolide, lincosamide and streptogramin (MLS) antibiotics 
 
The first macrolide antibiotic, erythromycin A, was isolated under the name ilotycin from 
Streptomyces erythreus (McGuire et al. 1952), currently known as Saccharopolyspora erythraea. 
Erythromycin contains a 14-member lactone ring to which two cyclic saccharides, desosamine 
and cladinose, are attached (Figure 2.2A). The monocyclic lactone ring (also termed aglycone) is 
a structural element present in all macrolides. The highly substituted ring has between 12 to 16 
members (Figure 2.2G), and one or more saccharides glycosidically attached to hydroxyl groups 
on either the aglycone or another saccharide (Kirst 2001). Naturally occurring macrolides have 
an aglycone size of 12, 14 or 16 members (Kirst 2005). Numerous semisynthetic macrolide 
derivatives have been constructed, some with deviating ring member numbers like the 15-
membered azithromycin (Figure 2.2B). 
Lincosamides and streptogramins are placed in the same antibiotic class with macrolides 
(WHOCC 2011). Although structurally very different, all three groups share a similar mode of 
action and resistance pattern (Vannuffel and Cocito 1996, Tenson et al. 2003, Roberts 2008). 
Lincosamides contain a proline residue attached by a peptide bond to a galactoside ring (Figure 
2.2C) (Canu and Leclercq 2009). Streptogramins comprise of two components, streptogramin A 
(e.g. dalfopristin, pristinamycin II, or virginiamycin) and streptogramin B (e.g. quinupristin, 
pristinamycin I, or virginiamycin S) (Vannuffel and Cocito 1996) (Figures 2.2D and 2.2F). 
When streptogramin A or B components are applied singly, they have a bacteriostatic effect. 
However, together the components exert a strong synergistic bactericidal effect caused by mutual 
stimulation of the drug-ribosome interaction (Vannuffel and Cocito 1996, Porse and Garrett 
1999).  
Ketolides are the latest generation of antibiotics derived from erythromycin A by removal of the 
3-L-cladinose sugar moiety and oxidation of the resulting 3-hydroxyl to a keto group (Figure 
2.2E) (Douthwaite and Champney 2001). The 3-keto group is responsible for evading certain 
resistance mechanisms, and the C11-C12 carbamate residue as well as the groups substituting it 
help overcome further resistance mechanisms and enhance in vivo activity (Bryskier 2000).  
MLS antibiotics exert their bacteriostatic activity by interacting with the 23S rRNA (especially 
intimately with A2058) of the 50S ribosomal subunit and to a lesser extent with L22 and L4 
proteins (Bryskier 2000, Mankin 2008). This interaction blocks the peptide chain exit tunnel or 
directly inhibits the peptidyl transferase activity, causing dissociation of the nascent peptidyl-
tRNA and inhibition of translation elongation (Tenson et al. 2003, Mankin 2008). In addition, 
macrolides and ketolides are able to inhibit the assembly of the 50S ribosomal subunit, and many 
carbamate ketolides inhibit assembly of the 30S subunit as well (Bryskier 2000, Douthwaite and 
Champney 2001). MLS antibiotics are broad-spectrum antibiotics whose activity covers both 
anaerobic and aerobic bacteria including gram-positive cocci and bacilli and gram-negative cocci 
(Canu and Leclercq 2009). Gram-negative bacilli are generally resistant with the exception of 
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some clinically important genera, i.e. Bordetella, Campylobacter, Chlamydia, Helicobacter, and 
Legionella. 
Depending on the country, MLS is the third or fourth most used class of veterinary 
antimicrobials in Europe (EMA 2011). In 2009, macrolides/lincosamides accounted for 3.6% of 
veterinary antibiotic sales in Finland, whereas in Denmark, the corresponding figure was 13.4%. 
In the WHO (2009) ranking of antimicrobials important for human medicine, macrolides are not 
only classified as critically important, but are among the the top three critically important 
antimicrobial groups along with quinolones and 3
rd
 and 4
th
 generation cephalosporins. This is 
because macrolides are widely used in food animal production and are known to select for 
macrolide-resistant Campylobacter spp. in animals. At the same time, macrolides are one of few 
available therapies for serious Campylobacter spp. infections in humans. Streptogramins have 
been listed as critically important, and lincosamides as important to human medicine. 
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Figure 2.2. Structures of macrolide, lincosamide and streptogramin antibiotics. A) Erythromycin A, 14-
membered macrolide. Of the two cyclic saccharides, desosamine is pictured above the cladinose residue.; 
B) Azithromycin, 15-membered macrolide; C) Lincomycin, lincosamide; D) Pristinamycin IA, 
streptogramin B component of pristinamycin; E) Telithromycin, 14-membered ketolide; F) Pristinamycin 
IIA, streptogramin A component of pristinamycin; G) Tylosin, 16-membered macrolide. The linked 
saccharides are mycinose (left), mycaminose (right) and mycarose linked to mycaminose.   
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2.2 Nisin, a lantibiotic bacteriocin 
 
In addition to tetracycline amd MLS antibiotic analytes, this study includes development of a 
whole-cell biosensor assay for nisin, a lantibiotic and a bacteriocin. Like classical antibiotics, 
lytic agents and lysozymes, bacteriocins are antimicrobial agents produced to inhibit competing 
micro-organisms of the same niche, and have also been suggested to be used in acquiring 
transforming DNA from other species (Kreth et al. 2005, Riley 2011). Bacteriocins are defined 
as ribosomally produced protein antibiotics that have a relatively narrow killing spectrum, and to 
which the producer organism has an immunity mechanism (Cotter et al. 2005, Riley 2011). 
Classical peptide antibiotics are not ribosomally synthesized.   
Bacteriocins are produced by a wide range of other bacteria including Gram-positive and Gram-
negative species (Jack and Jung 2000). Gram-negative bacteriocins assemble into two families: 
high mass (30–80 kDa) colicins and low mass (1–10 kDa) microcins (Rebuffat 2011). 
Bacteriocins produced by lactic acid bacteria (LAB) were divided into four classes by 
Klaenhammer (1993), and this classification has since been modified and extended to cover all 
Gram-positive bacteriocins (Rea et al. 2011) (Table 2.2.).  
Lantibiotics make up bacteriocin class Ia (Table 2.3). They are peptides ribosomally synthesized 
and posttranslationally modified to their active forms (Kuipers et al. 2011). Lantibiotics contain 
the unusual amino acids meso-lanthionine (Lan) and/or β-methyllanthionine (MeLan) (Figure 
2.3A). Other unusual amino acids such as 2,3-didehydroalanine (Dha, dehydrated serine) and 
(Z)-2,3-didehydrobutyrine (Dhb, dehydrated threonine), lysinoalanine, hydroxyproline, D-
cysteine etc. can be present (McAuliffe et al. 2001, Field et al. 2010). Lanthionines are 
embedded within cyclic lanthionine and methyllanthionine rings generated by intramolecular 
addition of cysteines to the dehydro amino acids (Figure 2.3B) (Chatterjee et al. 2005).  
 
 
 
 
Table 2.2. Classification of bacteriocins produced by Gram-positive bacteria (Rea et al. 2011). 
Class Characteristics Subclasses 
Class I Post-translationally modified peptides  
a) Lantibiotics 
b) Labyrinthopeptins 
c) Sactibiotics 
 
Four subclasses I–IV 
 
Two subclasses:  
single- and two-peptide bacteriocins 
Class II Non-modified peptides 
a) Pediocin-like 
b) Two-peptide bacteriocins 
c) Circular bacteriocins 
d) Linear non-pediocin-like one-peptide 
bacteriocins 
 
Four subclasses I–IV 
Two subclasses A and B 
Two subclasses 1 and 2  
Bacteriolysins Non-bacteriocin lytic proteins  
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Table 2.3. Classification of lantibiotics (Capstick et al. 2007, Goto et al. 2010, Rea et al. 2011). 
Modifying proteins are responsible for catalyzing the formation of lanthionine structures. 
Subclass Modifying 
protein 
Description and characteristic 
members 
Subclass Modifying 
protein 
Description and characteristic 
members 
I LanBC Linear antimicrobial peptides. 
Secretion by ABC transporter 
LanT. 
 
Nisin, subtilin 
III RamC Non-antimicrobial peptides 
involved in morphogenesis of 
streptomycetes. 
 
SapB, AmfS, SapT 
II LanM Globular antimicrobial peptides. 
LanT has a dual function of 
secretion and modification. 
 
Lactocin S, lacticin 3147 
IV LanL 
 
Non-antimicrobial peptide of 
unknown function. 
 
 
Venezuelin 
 
 
 
 
 
 
 
 
 
 
Figure 2.3. Structural motifs encountered in lantibiotics and structure of nisin. A) Abu, aminobutyrine; 
Ala, alanine; Dha, 2,3-didehydroalanine; Dhb, (Z)-2,3-didehydrobutyrine. B) The five lanthionine rings 
formed by addition of cysteines to Dha and Dhb residues are visible in the structure of nisin, the most 
studied lantibiotic. Above: molecular structure; below: ribbon structure. Adapted from Chatterjee et al. 
(2005).   
A) B) 
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Bacteriocins naturally produced by LAB are exploited by the food industry for food-grade 
control of bacterial spoilage (Cleveland et al. 2001, Chen and Hoover 2003, Cotter et al. 2005, 
Deegan et al. 2006, Gálvez et al. 2007). The use of nisin (Figure 2.3B) as a food preservative is 
approved in more than 80 countries (Delves-Broughton et al. 1996, Delves-Broughton 2005, 
Gálvez et al. 2011). In the EU, Directive 95/2/EC sets a maximum level of 3–12.5 mg/kg for 
nisin in various foodstuffs (EC 1995). In addition to food preservation, nisin is used or shows 
potential in medical applications such as contraceptive and disinfectant use, acne and mastitis 
treatment, tooth decay prevention and treatment of systemic, upper respiratory tract and ear 
infections (Reddy et al. 2004, Field et al. 2010, Dicks et al. 2011).  
Nisin is the most studied bacteriocin, and a prototype lantibiotic. Several natural variants of nisin 
are known that differ in amino acid sequence but share an  identical pentacyclic lanthionine ring 
structure: nisin A (Gross and Morell 1971), nisin Z (Mulders et al. 1991), nisin Q (Zendo et al. 
2003), nisin U and nisin U2 (Wirawan et al. 2006), and nisin F (de Kwaadsteniet et al. 2008). All 
variants are produced by Lactococcus lactis except nisins U and U2 which are expressed by 
Streptococcus uberis.  
Nisin exerts its antibacterial activity by forming pores in the cell membrane which leads to 
release of ions, amino acids, and ATP, and causes a collapse of the proton motive force and 
dissipation of the transmembrane pH gradient (Moll et al. 1997, Kuipers et al. 2011). Pore 
formation occurs through interaction with lipid II, a precursor of cell wall synthesis (Hasper et 
al. 2004). Displacement of lipid II by nisin also leads to inhibition of cell wall synthesis 
(Lubelski et al. 2008). Nisin also inhibits the outgrowth of bacterial spores, possibly through 
interaction of the dehydroalanine groups with spore membrane sulfhydryl groups (Morris et al. 
1984). The antimicrobial spectrum of nisin covers a wide range of genera, including pathogens 
like Gram-positive Listeria, Staphylococcus, and Clostridium, as well as Gram-negative 
Campylobacter jejuni and Helicobacter pylori (Mota-Meira et al. 2000).  
Bacteriocins have been suggested to form the next generation of antimicrobials (Gillor et al. 
2005) since resistance to bacteriocins is infrequent and easily outcompeted by nonresistant 
strains (Dicks et al. 2011). As an example of this, nisin has been used as a food preservative for 
several decades without induction of widespread resistance (Christianson 2006). In addition to 
exploiting natural variants, bacteriocins may act as models for the design of novel antibiotics 
(Pag and Sahl 2002). Altered variants with enhanced antimicrobial activity have been 
constructed by modifying bacteriocin structural genes, and enzymes responsible for 
posttranslational modification have been utilized in introducing modifications in non-lantibiotic 
peptides to increase activity and protease resistance (Field et al. 2008, 2010, Kluskens et al. 
2009, Kuipers et al. 2011).   
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3 ANTIBIOTIC USE AND ITS CONTROL 
 
The discovery of traces of tetracycline in humal skeletal remains form Sudanese Nubia 
demonstrates that the ability to produce tetracycline through fermentation processes was 
occurring almost 2000 years ago (Bassett et al. 1980, Nelson et al. 2010). Another study of 
human skeletal material demonstrates possible health benefits of antibiotic use through low rate 
of infectious diseases in the Sudanese Nubian population (Armelagos 1969). During the post-
World War II modern antibiotic era, antibiotics along with improved sanitation and application 
of vaccination have contributed significantly to the control of infectious diseases that were once 
among the leading causes of human morbidity and mortality (CDC 1999, Aminov 2010). Over 
the period 1937–1953, the annual decline in mortality rate in the United States increased from 
2.3% to 8.2%, coinciding with commencement of clinical use of sulfonamides (1935), 
benzylpenicillin (1941) and streptomycin (1943) (Armstrong et al. 1999). 
Veterinary antibiotic use has contributed to improvements in animal health and welfare and to a 
marked increase in productivity of livestock for human consumption (EMEA 1999). In animal 
husbandry, antibiotics are used for disease therapy and control as well as growth promotion. 
Disease control refers to prophylactic treatment of all animals in a group when one or a number 
of group members show signs of disease (Gustafson and Bowen 1997). Growth promotion with 
subtherapeutic doses of antibiotics increases viability, rate of weight gain, and reduces the 
amount of feed per unit of gain (Gustafson and Bowen 1997, Dibner and Richards 2005). Several 
mechanisms are associated with growth promotion: decreased competition of nutrients and 
reduction of growth-limiting microbial metabolites due to diminished numbers of gut microbiota, 
enhanced nutrient digestibility due to thinning of the gut wall and intestinal villi, reduction in 
opportunistic pathogens and subclinical infection, and finally, decreased continuous host immune 
stimulation by microflora (Visek 1978, Gaskins et al. 2002, Dibner and Richards 2005).  
From the moment antibiotics were discovered, they have been used excessively and with little 
attention to the inevitable consequence of resistance (Dryden et al. 2009). Antibiotics not only 
act on the pathogenic bacteria causing the infection, but also on a myriad of commensal bacteria. 
These can then disseminate widely, creating a reservoir of resistant organisms (Wright 2007, 
Carlet et al. 2011). The first reports of resistance to antibiotics appeared shortly after the earliest 
clinical trials and therapeutic use of antibiotics commenced in the 1940’s (Abraham and Chain 
1940, Waksman et al. 1945, Miller and Bohnhoff 1946).  
To add to the problem of increasing resistance, the discovery and development of new antibiotics 
has almost stopped since pharmaceutical companies withdrew from antibacterial R&D in the 
1990s or earlier (Theuretzbacher 2009, Shryock and Richwine 2010). The reasons are many: 
focusing on products of higher profit and short-term returns, shrinking margins caused by low 
reimbursement rates and generic products, difficulty of creating new classes of antibiotics to 
meet increasing antibiotic resistance, pressure to use new compounds sparingly to avoid 
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resistance, and inconsistency of regulatory policies leading to uncertainty over final approval of 
the drug (Christoffersen 2006, Shryock and Richwine 2010). The interest of the pharmaceutical 
industry in antimicrobials is, however, returning in the form of premium-priced narrow-spectrum 
antibiotics for targeted therapy of multidrug-resistant bacteria (Theuretzbacher 2009). 
 
3.1 Human and animal use of antibiotics in numbers 
 
The antibiotics market amounted to global sales of US$ 25 billion in 2005 and US$ 42 billion in 
2009, representing 5% of the global pharmaceutical market (Hamad 2010). Cephalosporins are 
the antibiotic class bringing in the highest revenue, owning more than one quarter of total global 
market (Figure 3.1). The total global usage of antibiotics is estimated to be between 100 000 and 
200 000 tons per year (Moreno-Bondi 2009) including antibiotics used in human and veterinary 
medicine and as growth promoters. Veterinary antibiotics make up approximately one-third of 
total antibiotic sales in the EU (Moreno-Bondi 2009), yielding sales of 705 million € in 1996 
(EMEA 1999).  
The use of veterinary medicinal antibiotics in the EU grew from approximately 3500 tons in 
1997 to almost 5400 tons in 2004, a 54% increase (Table 3.1). The majority of this increase 
results from the gradually enforced (from 1999 to 2006) EU ban of using antibiotics for growth 
promotion that led to an increase in the use of therapeutic antibiotics contrary to the intended 
effect (Casewell et al. 2003, Stolker et al. 2007). However, the increase in veterinary usage 
leveled off between years 2005–2009 (EMA 2011). Figure 3.2 presents the use of antibiotics for 
human and veterinary medicine in France in from 1999 to 2005. France uses the highest amount 
of antibiotics in veterinary medicine in the EU as the country is among the top meat producers in 
the Union area. Unlike in the EU, in France total veterinary usage exceeds total human medicinal 
use (Moulin et al. 2008). Tetracyclines are the most used and MLS the third most used veterinary 
antibiotic class in France. However, the profile of antibiotic usage varies between different EU 
countries. In 2009, tetracyclines and macrolides/lincosamides accounted for 13.8% and 3.6% of 
sales of veterinary antibiotics in Finland, respectively, whereas in the Netherlands, the 
corresponding sales were 52.0% and 9.2% (EMA 2011). 
 
Table 3.1. Antibiotic use in the EU and Switzerland in metric tons.  
Year Human medicine Veterinary medicine Growth promotion Total Ref. 
1997 7659 t (60%) 3494 t (27%) 1599 t (13%) 12 752 t (100%) [1],[2] 
1999 8528 t (65%) 3502 t (29%) 786 t   (6%) 13 216 t (100%) [2],[3] 
2004 n.d. 5393 t * n.d. n.d. [4] 
References: [1] EMEA 1999, [2] Ungemach et al. 2006, [3] Moreno-Bondi 2009, [4] Kools et al. 2008. N.d. = not 
determined. *estimated use in the EU. 
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Figure 3.1. Global sales of antibiotics by class in 2009 (Hamad 2010). 
 
 
Figure 3.2. Veterinary and human medicinal usage of various antibiotic classes in France (adapted from 
Moulin et al. 2008).  
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3.2 Threats related to (mis)use of antibiotics 
Human and animal health are integrally associated, as shown by zoonotic i.e. animal-originating 
pathogens such as Listeria, Salmonella, Campylobacter and Escherichia coli O157 (Aarestrup 
and Wegener 1999). Close relations exist between human and veterinary medicine, not just 
through diseases shared or transmitted from animal to human or vice versa, but also by common 
therapeutic agents and treatment methods (Currier and Steele 2011). Antibiotics are jointly used 
as a treatment for bacterial infections, and as a consequence, a pool of antibiotic resistance has 
emerged that has potential to spread between animals and men.  
Antibiotics are misused through self-medication, prescription-free over the counter availability, 
and needless prescription to treat viral infections (Dryden et al. 2009). Also, antibiotics are 
overused in farmed animals through disease-control practices and increasing non-therapeutic 
(metaphylaxis/growth promotion) use (Carlet et al. 2011). It has been estimated that up to 50% 
of human antibiotic use and up to 80% of veterinary antibiotic use could be eliminated without 
serious consequence (Wise et al. 1998). Simultaneously, there are increasing demands for over 
the counter availability of antibiotics in order to reduce healthcare costs by encouraging patients 
to self-medicate (Dryden et al. 2009). Applications for prescription-free trimethoprim and 
nitrofurantoin in the UK were withdrawn in 2010 after much debate over associated risks 
(Dryden et al. 2009, Andalo 2010), but an application for release of trimethoprim to pharmacy 
availability has recently been submitted in New Zealand (Pharmacybrands Ltd. 2012).  
Animals are treated to a lesser extent with antibiotics than humans: a 6.3-fold higher use of 
antibiotics in mg/kg of body mass per year has been estimated in humans (Ungemach et al. 
2006). However, the conditions of antibacterial use in farm animals exert a high pressure for 
selection of resistance (Aarestrup and Wegener 1999, Cogliani et al. 2011). Over 80% of 
antibiotics are administered to food animals via oral flock treatment, in which whole animal 
herds are under long-term exposure to low levels of broad-spectrum antibiotics, and the risk for 
underdosing is high (Ungemach et al. 2006). Low concentrations of antibiotics have been 
discovered to cause radical-induced random mutagenesis, which in turn creates multidrug 
resistance to antibiotics also other than the one used for treatment (Kohanski et al. 2010a).  
Nontherapeutic antibiotics are typically administered orally, and as antibiotics are typically 
poorly adsorbed in the gut, the majority is excreted unchanged in urine and feces (Sarmah et al. 
2006). Antibiotic metabolites can also be antimicrobially potent, or can be transformed back to 
the parent compound (Aerts et al. 1995, Sarmah et al. 2009). Presence of antibiotic residues in 
urine and feces leads to spread of the drugs in the environment through wastewater or use as 
fertilizers. In addition, antibiotics can be disseminated in the environment through flushing of 
out-of-date or unused prescriptions, leakage from septic systems, land application of human, 
medical or agricultural waste, or direct application of antibiotics in the environment through 
aquaculture or plant spraying (Sarmah et al. 2006, Allen et al. 2010, Davies and Davies 2010). 
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These residues may assist in maintaining or developing antibiotic resistant microbial populations 
(Ghosh and LaPara 2007).  
Not only antibiotics themselves should be considered a source of environmental pollution. Waste 
material from farms, homes and hospitals contains human- or animal-associated microbiota 
carrying antibiotic resistance determinants that can play a role in spreading of resistance in the 
environment (Martinez 2009, Allen et al. 2010). It is generally accepted that antibiotic therapy 
and growth promotion select for and increase the prevalence of antibiotic resistance in animal-
associated microbiota (Aarestrup et al. 2000, Wright 2007, Davies and Davies 2010, Oliver et al. 
2011, Carlet et al. 2011). It is, however, unclear whether the pool of resistance genes generated 
by antimicrobial use in food animals significantly influences the prevalence of therapeutic 
failures in humans (Cox and Ricci 2008, Wright 2010). The resistance problem in humans has 
mainly risen from human use, and antibiotic use in food animals may reduce the risk of zoonotic 
transmission of animal pathogens to humans (Gustafson and Bowen 1997, Casewell et al. 2003 
Phillips et al. 2004, Cox and Ricci 2008). However, there are examples of human commensal 
and pathogenic isolates that are resistant to antibiotics used only in veterinary science, and 
evidence of transfer of human (multiresistant) pathogens to animals and vice versa (Aarestrup 
and Wegener 1999, van den Bogaard et al. 2000, Strommenger et al. 2006, Hunter et al. 2010).  
Food is considered to be the most important vector for spread of resistance between humans and 
animals (WHO 2009). Evidence exists that ingestion of food contaminated by resistant bacteria 
selected in animals may lead to transfer of resistance determinants to bacteria in the human gut, 
or cause an infection in which therapy is compromised (Teale 2002, Cox and Ricci 2008, Allen 
et al. 2010). In addition, antibiotic residues in food products, a by-product of antibiotic use 
(Aerts et al. 1995), may allow the selection of antibiotic-resistant bacteria after the food is 
consumed (McDermott et al. 2002). There has been some concern about allergic reactions and 
toxicity effects caused by antibiotic residues in food, but the residue levels are generally too low 
to cause these adverse effects (Black 1984). Only a few reports on allergic reactions to β-lactam 
residues in milk exist (Dewdney et al. 1991). 
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3.3 Antibiotic resistomes  
 
The discovery of tetracyclines in 1948 was soon followed by the first report of tetracycline 
resistance in 1953 (Roberts 1996). This was inevitable, since all bacteria harbor some degree of 
innate antibiotic resistance due to nonspecific efflux systems for expulsion of toxins, and most 
bacteria also have a reservoir of genes for more specific resistance towards antibiotics (Wright 
2007, Allen et al. 2010, Davies and Davies 2010). In addition, bacteria can acquire specific and 
nonspecific resistance mechanisms through horizontal gene transfer: DNA can be taken up 
through transformation, conjugation or transduction of mobile genetic elements such as 
plasmids, insertion sequences, transposons and integrons (Schwarz and Chaslus-Dancla 2001, 
Partridge 2011). For the most part, these resistance elements originate from antibiotic producer 
self-protection mechanisms, and have likely been circulating in bacterial populations for 
millennia (Allen et al. 2010). However, mobile genetic elements frequently include co-selected 
multiple resistance genes encoding diverse modes of resistance to several antibiotic classes 
(Partridge 2011). These resistance plasmids and ensuing multiresistant strains are a result of a 
recent evolution process intensified by human activities (Davies and Davies 2010, English and 
Gaur 2010). 
The increase in the number, diversity and range of resistant organisms has become an enormous 
clinical problem (Wright 2007). Selective pressure from antibiotic use has led to development of 
superbugs such as meticillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant 
enterococci (VRE), multiply resistant bacteria that are originally normal human commensal flora 
(Schwarz and Chaslus-Dancla 2001, Wright 2007, English and Gaur 2010). These together with 
natural superbugs, intrinsically multiply resistant opportunistic pathogens of environmental 
origin such as Pseudomonas aeruginosa and Acinetobacter baumannii, increasingly cause 
infections that either lead to or prolong hospitalization (Wright 2007, Davies and Davies 2010). 
Hospital acquired infections (HAI) caused by multiply resistant bacteria yearly affect around 7% 
i.e. over 4 million patients in the EU (ECDC 2008). Approximately 37,000 deaths are directly 
caused by HAIs, and they contribute to an additional 111,000 deaths. The total annual healthcare 
cost of nosocomial infections in the EU is estimated at € 7 billion. 
The resistome is the aggregate of all antibiotic resistance mechanisms in both pathogenic and 
non-pathogenic bacteria (Wright 2007, Davies and Davies 2010). As an example of a resistome 
to an antibiotic family, the tetracycline resistome is presented in Table 3.2. The four main 
mechanisms of resistance are (i) target protection i.e. weakened interaction of drug and ribosome 
by ribosomal protection proteins (RPP) competing of binding site, (ii) efflux of TCs by integral 
membrane transporter pumps, (iii) drug inactivation by enzymatic modification and (iv) target 
modification, i.e. binding site modifying mutation of 16S rRNA (Zakeri et al. 2008, Thaker et al. 
2010). Tet genes encoding TC resistance determinants are well conserved and widely expressed 
across various bacterial genera and species both aerobic and anaerobic as well as Gram-positive 
and Gram-negative (Li and Nikaido 2009, Macauley et al. 2007, Roberts 2003, Roberts 2005). 
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The list of macrolide, lincosamide, streptogramin (MLS) group resistome genes has grown from 
44 known in 1999 to 66 in 2008 and 78 in 2011 (Roberts et al. 1999, Roberts 2008, 2011). These 
genes encode proteins providing four types of resistance mechanisms: (i) target-modifying rRNA 
methylases, (ii) efflux pump proteins, (iii) drug inactivating enzymes including esterases, lyases, 
transferases, and phosphorylases, and (iv) a rRNA methyltransferase. The rRNA 
methyltransferase has been classified separately since it confers resistance to lincosamides and 
streptogramin A but not macrolides. The other rRNA methylases generally give resistance to 
macrolides, lincosamides and streptogramin B antibiotics. In addition to the four classes 
mentioned above, mutant forms of 23S rRNA and ribosomal protein L4 and L22 genes have 
been identified that confer resistance to MLS antibiotics (Roberts 2008, Canu and Leclerq 2009) 
and could be included in the classification as a fifth group. Macrolide resistance is widespread in 
Gram-negative bacteria, most of which are intrinsically resistant to MLS antibiotics (Gibreel and 
Taylor 2006, Canu and Leclerq 2009). Macrolide resistance has been detected in a vide variety 
of Gram-positive bacteria including clinically relevant genera such as Enterococcus, 
Streptococcus, Bacillus, Staphylococcus, Mycobacterium, and Clostridium (Roberts et al. 1999, 
Jensen et al. 2002, Jalava et al. 2004).  
Resistance to nisin is inherent in nisin producers that must harbor resistance genes to avoid auto-
toxicity (Christianson 2006, Lubelski et al. 2008). On the nisin biosynthesis operon, nisIFEG 
genes are involved in producer self-protection. NisFEG form an ATP-binding cassette (ABC) 
transporter complex to extrude nisin from the membrane to the extracellular environment (Patton 
and van der Donk 2005, Lubelski et al. 2008). NisI reduces nisin concentration by sequestering 
nisin possibly through co-operation with NisFEG (Takala et al. 2004). Nisin resistance has been 
reported in nisin non-producing Listeria monocytogenes (Gravesen et al. 2001), Bacillus subtilis 
(Hansen et al. 2009, Staroń et al. 2011) and Staphylococcus aureus (Blake et al. 2011, Hiron et 
al. 2011). Nisin resistance is attributed to upregulation of ABC transporters, VraED in S. aureus 
and PsdAB and YvcRS in B. subtilis, that are involved in resistance to nisin and other peptide 
antibiotics in an unknown manner (Blake et al. 2011, Hansen et al. 2009, Hiron et al. 2011, 
Staroń et al. 2011). Bacteriocins have been suggested to form the next generation of 
antimicrobials (Gillor et al. 2005) since resistance to bacteriocins is infrequent (Dicks et al. 
2011). However, these newly discovered peptide antibiotic resistance mechanisms may change 
this outlook. 
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Table 3.2. Tetracycline resistance mechanisms and proteins. TMS, transmembrane sequence; MFS, 
Major facilitator superfamily. Nomenclature and classification according to Levy et al. 1999, Roberts 
2005 and Thaker et al. 2010. 
Resistance type Mode of action and details Members References 
Target protection by 
ribosomal 
protection proteins 
 
Weakening of the interaction between TC 
and ribosome causes TC dissociation. 
Simultaneous GTP hydrolysis leads to 
dissociation of RPP from the ribosome. 
 
RPPs share high homology to translation 
elongation factors EF-Tu and EF-G, and 
are proposed to be EF paralogs. 
 
Grouping based on the extent of amino 
acid sequence identity.  
Group 1: Tet(M), Tet(O), Tet(S), Tet(W), 
Tet(32), Tet(36), Tet(44) 
 
Group 2: TetB(P), Otr(A), Tet 
 
Group 3: Tet(Q), Tet(T) 
 
Mosaic genes i.e. hybrids of known RPP 
genes also exist. Examples:  
Tet(O/32/O), Tet(O/W/32/O/W/O). 
[1], [11], 
[12] 
Efflux pumps Integral membrane drug-H+ antiporters. 
The exchange of antibiotic for H+ creates 
a proton flow which provides energy for 
pumping. 
 
Members of the major facilitator 
superfamily (MFS) with 12–14 TSMs. 
Also some atypical MFS and non-MFS 
protein pumps 
 
 
Group 1: 12 TMSs, MFS. 
Tet(A), Tet(B), Tet(C), Tet(D), Tet(E), 
Tet(G), Tet(H), Tet(Y), Tet(Z), Tet(30), 
Tet(31), Tet(33), Tet(39), Tet(41), 
Tet(42) 
 
Group 2: 14 TMSs, MFS, non-
Streptomyces origin.  
Tet(K), Tet(L) 
 
Group 3: 14 TMSs, MFS, Streptomyces 
origin.  
OtrB, Tcr3 
 
Group 4: 12 TMSs, atypical MFS.  
TetA(P), Tet(40) 
 
Group 5: ≥ 10 TMSs, atypical MFS.  
Tet(V) 
 
Group 6: 9 TMSs, non-MFS. 
Tet(35), OtrC 
 
Group 7: 14 TMSs, MFS, non-
Streptomyces origin, not homologous to 
Tet(K).  
Tet(38) 
[2], [3], [4], 
[5], [6], [7], 
[8], [11], 
[12] 
Drug inactivation Enzymatic inactivation by addition of a 
hydroxyl group to C-11a position. 
 
Mechanism also inactivates tigecycline. 
Tet(X) 
 
Proposed members Tet(37) and Tet(34) 
(activity not confirmed) 
[9], [12], 
[13] 
Target modification Mutant forms of the TC target, bacterial 
ribosome 16S rRNA. 
(G  C) at position 1058 
(AGA  TTC) at positions 926 - 928 
[10], [12] 
[1] Abril et al. 2010, [2] Agersø and Guardabassi 2005, [3] Brown et al. 2008, [4] Hansen et al. 1993, [5] Gordon et al. 2008, [6] 
Marshall et al. 1986, [7] McMurry et al. 1987, [8] McMurry et al. 1998, [9] Moore et al. 2005, [10] Ross et al. 1998, [11] Sloan 
et al. 1994, [12] Thaker et al. 2010, [13] Volkers et al. 2011.  
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3.4 Controlling measures on the use of antimicrobials 
 
Growth enhancement use of antibiotics in the 1950’s and 1960’s led to an increase in antibiotic 
resistance in Salmonella strains associated with calf disease (EMEA 1999). Emergence of 
resistance led in the UK to the setting up of a Joint Committee on the Use of Antibiotics in 
Animal Husbandry and Veterinary Medicine, which in its 1969 report recommended antibiotics 
with therapeutic value should not be applied as growth promoters (House of Lords 1998). This 
“Swann Report” was the first action to begin the much-needed rationalization of antimicrobial 
use.  
The World Health Organization (WHO) acknowledged the high importance of antimicrobial 
resistance as a threat to human and animal health by declaring antimicrobial resistance the topic 
of World Health Day 2011. WHO has devised a strategy for containment of antimicrobial 
resistance (2001a) as well as guidelines for rational drug use in humans (2002, 2007) and 
surveillance of antimicrobial resistance (2001b). WHO (2009) has also created a ranking of 
antibiotics critically important for human medicine which is intended to help develop prudent 
antimicrobial use in agriculture and veterinary medicine.  
Responsible veterinary and agricultural use of antibiotics has been considered by international 
organizations such as World Organization for Animal Health (OIE), Codex Alimentarius and 
World Veterinary Assiciation (WVA), which have published guidelines for prudent use of 
antimicrobial products in food animals (Codex Alimentarius 2005, OIE 2011, WVA 2011). 
Guidelines for responsible use of antimicrobials in human medicine have been provided in the 
U.S. by CDC - Centers for Disease Control and Prevention and in the EU by the European 
Council (Gonzales et al. 2001a, 2001b, EC 2002a, Dellit et al. 2007). Countries like Brazil, 
South Korea, Canada, Australia and New Zealand have also implemented policies and 
programmes to prevent the emergence of resistance through antibiotic stewardship i.e. 
appropriate antibiotic use (EC 2002a, Zoutman et al. 2003, Oh et al. 2006, Pagani et al. 2008, 
Guerra et al. 2010).  
The EU has recently devised a 5-year plan consisting of twelve key actions against antimicrobial 
resistance (EC 2011). The plan noted that EU recommendations for prudent use in veterinary 
medicine should be introduced. Also, existing resistance monitoring programs in the EU require 
harmonization regarding antimicrobials surveyed, definition of resistance, and epidemiological 
cut-off values i.e. minimum inhibitory concentrations (MIC) used for designating wild type and 
resistant strains (Silley et al. 2011).  
The EU has gradually enforced a total ban on use of growth promoters in food animals, taking 
full effect in 2006 (EC 2003b). The ban resulted in reduced antibiotic use and antibiotic 
resistance in animals. A temporary increase in the use of therapeutic antibiotics and in 
tetracycline and sulphonamide resistant Salmonella in animal and human infections was seen 
(Stolker et al. 2007, Casewell et al. 2003), but the increase in use has since leveled out (EMA 
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2011), and a decrease in antimicrobial resistance ensued (van den Bogaard et al. 2000, 
Bengtsson and Wierup 2006). Another example of successful control on antibiotic use comes 
from Germany: the national guidelines for prudent use of antibacterials in animals implemented 
in 2000 led to a 73% decrease in antibiotics prescribed as antibiotic-medicated feeding stuffs, 
and a 57% reduction in treatment days by the year 2002 (Ungemach et al. 2006).   
EU legislation enforces countries to establish and execute a national monitoring plan, under 
which a set percentage of animal products should be monitored for (antibiotic) residues and other 
contaminants to promote food safety by ensuring residues do not reach the consumers as well as 
to establish prudent use of antimicrobials (EC 1996). An EU Council Regulation for the 
establishment of maximum residue limits (MRL) of veterinary medicinal products in foodstuffs 
of animal origin became effective in 1990 and was repealed in 2009 by an update, which 
recognized the effect of progress in detection methods and pharmacological, toxicological and 
microbiological effect assessments to establishing MRLs (EC 1990, 2009). In 2010, MRLs of 
pharmacologically active substances were combined under a single Commission Regulation (EC 
2010a). EU MRLs for macrolide/lincosamide and tetracycline antibiotics are presented in Table 
3.3.  
The most recent annual report on the execution of EU national monitoring plans in 2009 (EC 
2010b) recounts 445.968 samples were tested under the monitoring plans, fulfilling the 
requirements of the minimal amount of samples to be tested (EC 1996, 1997). Of these, 155.432 
samples (34.9%) were tested for presence of antibacterials, and 332 samples (0.21%) were found 
noncompliant i.e. containing a concentration above the MRL. Of the noncompliant samples, 109 
were found in pigs, 68 in bovines, 50 in milk, 32 in poultry and the rest in sheep/goats (28), 
honey (23), rabbits (9), aquaculture (9), horses (2), farmed game (1), and eggs (1). Honey had the 
highest prevalence of noncompliance, with 23 (0.98%) samples out of 2336 testing positive. 
In Finland, the EU enforced national monitoring plan of animal product contaminants is enacted 
by the Ministry of Agriculture and Forestry (MAF) and executed by the Finnish Food Safety 
Authority Evira (MAF 2007, Forsbacka et al. 2011). In 2005, a total of 11.209 tests were carried 
out. The presence of antimicrobials was tested in 6.900 samples, with 3 (0.06%) pig samples and 
3 (3.61%) honey samples found noncompliant for antimicrobial substances (Saraste et al. 2006). 
Out of all samples tested, 99.7% were compliant. 
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Table 3.3. European Union MRLs in μg/kg for tetracyclines and macrolide/lincosamides in various edible 
tissues (EC 2010a). The table also indicates the species in which the use of each substance is allowed.  
Group Antibiotic Muscle Fat Liver Kidney Milk Eggs Species 
Tetracyclines Tetracycline 100  300 600 100 200 All food producing species a) 
 Oxytetracycline 100  300 600 100 200 All food producing species a) 
 Chlortetracycline 100  300 600 100 200 All food producing species a) 
 Doxycycline 100  300 600   Bovine b) 
  100 300 300 600   Porcine, poultry c) 
Macrolides Erythromycin 200 200 200 200 40 150 All food producing species a),d) 
 Gamithromycin  20 200 100   Bovine b) 
 Spiramycin 200 300 300 300 200  Bovine  
  200 300 400    Chicken c), d) 
  250  2000 1000   Porcine 
 Tilmicosin 75 75 1000 250   Poultry  c), d) 
  50 50 1000 1000 50  All other food producing 
species a),d) 
 Tulathromycin 100  3000 3000   Bovine b) 
  100  3000 3000   Porcine d) 
 Tylosin 100 100 100 100 50 200 All food producing species a),d) 
 Tylvalosin 50 50 50 50   Porcine 
   50 50    Poultry c) 
Lincosamides Lincomycin 100 50 500 1500 150 50 All food producing species a),d) 
 Pirlimycin 100 100 1000 400 100  Bovine 
a)
 For fin fish the muscle MRL relates to ‘muscle and skin in natural proportions’. MRLs for fat, liver and kidney do 
not apply to fin fish.  
b)
 Not for use in animals from which milk is produced for human consumption.  
c)
 Not for use in animals from which eggs are produced for human consumption.  
d)
 For porcine and poultry species the fat MRL relates to ‘skin and fat in natural proportions’. 
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4 DETECTION METHODS OF ANTIBIOTIC RESIDUES IN FOOD 
Antibiotics are considered one of the most significant groups of food contaminants (Kantiani et 
al. 2010). Antibiotic residues in products of animal origin are a by-product of antibiotic use 
formed through pharmacokinetic distribution of the drug within the body based on its 
physicochemical properties and metabolism (Sarmah et al. 2006). Over time, the drug and its 
metabolites are cleared from the body in excretions. Other factors which determine the 
occurrence of residues are the route of administration, contamination of feed or water, and the 
physical condition of the animal (Aerts et al. 1995). To avoid the appearance of residues in food, 
withdrawal periods have been assigned to various antibiotics based on pharmacokinetic data and 
elimination rates from the animal body (EC 1990, 2001, 2009). The withdrawl period is the span 
of time until a safe level in edible tissues and other products (milk, eggs, honey) is achieved. EU 
MRLs are the points of reference for the establishment of withdrawal periods (EC 1990, 2001, 
2009). Failure to observe withdrawal times, as well as improper treatment records, extended 
usage or excessive dosage of can lead to presence of antibiotic residues in concentrations above 
the MRLs in food products (Bovee and Pikkemaat 2009).  
European Commission Decision 2002/657/EC lays down performance and validation criteria for 
the screening and confirmatory methods used in national residue monitoring programs (EC 
2002b). Methods of analysis of antimicrobials can be grouped in three categories: 
microbiological, immunochemical, or physicochemical (EC 2010b). Microbiological methods 
are fast screening methods which allow a high sample throughput but limited information is 
obtained about substance identity and its concentration in the sample. Immunochemical methods 
are rapid, selective, and sensitive and are widely applied in some areas of residue analysis, 
typically in screening for substances that cannot be discerned by microbiological growth 
inhibition. Physicochemical methods allow an accurate identification and quantification of the 
substance, and are therefore applied in confirmatory analysis of suspect samples identified by 
screening methods.  
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4.1 Confirmatory analysis of antibiotic residues 
Physicochemical methods are typically used in confirmatory analysis of the presence and 
concentration of antibiotic residues in products of animal origin after they have been indicated by 
a screening test (EC 2010b). A confirmatory test involves a more sophisticated testing method 
providing full or complementary information enabling the substance to be identified precisely 
and confirming that the MRL has been exceeded (EC 2010b). Confirmatory methods are 
typically not suitable for screening since they are time-consuming, expensive, and require 
complex laboratory equipment as well as trained personnel (Cháfer-Pericás et al. 2010). Also, 
they typically require extensive sample-preparation based on liquid and solid-phase extraction 
and multi-step clean-up (Kinsella et al. 2009). 
European Commission Decision 2002/657/EC lists suitable methods for quantitative 
confirmatory analysis of antibiotic residues (EC 2002b). These consist of chromatographic 
separation in combination with detection (Table 4.1.). The Decision also introduces identification 
points (IP), the basic idea of which is that a laboratory is allowed to use any spectrometric 
technique or combination of techniques to earn a minimum number of IPs necessary for proper 
identification of a component (Stolker et al. 2000). The minimum amount of IPs for 
identification of antimicrobials is three. As a consequence, methods based on chromatographic 
analysis followed by mass spectrometric detection are becoming the norm in confirming 
antibiotic residue identity and determining concentration (Stolker et al. 2007, McGlinchey et al. 
2008, Boscher et al. 2010).  
Alternative physicochemical methods for confirmatory analysis include capillary electrophoresis, 
which has been used to detect antibiotics in food matrices (García-Ruiz and Marina 2006). 
However, although the technique is less expensive and has higher separation efficiency than 
HPLC methods, the lower sensitivity of capillary electrophoresis may prevent detection at MRL 
(Hernández et al. 2003, McGlinchey et al. 2008). Immunoanalytical methods such as 
radioimmunoassays, fluoroimmunoassays, and the most commonly used enzyme-linked 
immunosorbent assays (ELISA) are quantitative and have  a high sensitivity, capacity for high- 
 
Table 4.1. Suitable confirmatory methods for veterinary drugs or contaminants in products of 
animal origin according to European Commission Decision 2002/657/EC. (EC 2002b). 
LC or GC with mass-spectrometric detection 2-D TLC-full-scan UV/VIS 
LC or GC with IR spectrometric detection GC-electron capture detection 
LC-full-scan DAD LC-immunogram 
LC -fluorescence LC-UV/VIS (single wavelength) 
LC, liquid chromatography; GC, gas chromatography; IR, infrared spectrometry; DAD, diode array detection; TLC, 
thin layer chromatography; UV/VIS ultraviolet/visible spectrophotometry; HPTLC, high-performance thin layer 
chromatography. 
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throughput, and often do not require complex sample clean-up (Pastor-Navarro et al. 2009). 
However, immunoassays are generally group-specific by nature, and therefore cannot offer direct 
identification of the analyte due to cross-reactivity towards structurally similar antibiotics 
(Korpimäki et al. 2004). Therefore, they are often better suited for use as screening methods. 
As mentioned above, LC-MS methods form the majority of routine confirmatory methods, but 
other methods are also validated along the guidelines. Table 4.2 presents a selection of validated 
confirmatory methods for tetracycline and macrolide/streptogramin/lincosamide residues and 
briefly describes sample preparation and clean-up steps necessary for each method. In addition to 
the extraction and filtration steps described in Table 4.2, solvent changes by evaporation were 
often a part of the cleanup process, and the final step before LC analysis. Most methods 
described in Table 4.2 represent multiresidue methods which can detect antibiotics from other 
classes than TC and MLS groups (Granelli and Branzell 2007, Carretero et al. 2008, Chico et al. 
2008, Kaufmann et al. 2008, Stolker et al. 2008, Granelli et al. 2009, Peters et al. 2009, Boscher 
et al. 2010, Dasenaki and Thomaidis 2010, Lopes et al. 2012, Tang et al. 2010), but results 
regarding only these two classes are concentrated upon. The methods mainly originate from 
different EU countries and have been validated for various food matrices in order to be applied in 
carrying out the national residue monitoring plan.  
European Commission Decision 2002/657/EC states that as a part of assay validation, a decision 
limit (CC) must be established for confirmatory methods used for identification and 
quantification of substances with an established MRL. CC is the limit at and above which a 
sample is considered to be noncompliant with an error probability  of 5%. Therefore, it can be 
concluded with 95% certainty that a sample is non-compliant. Also a detection capability (CC) 
must be established for confirmatory methods, although it is considered more important in 
validation of screening methods. Methods used for residue detection of substances with an 
established MRL, such as antibiotics, must have a detection capability with a false compliant rate 
< 5% (EC 2002b). In other words, CCβ is the smallest amount of analyte that can be detected in 
a sample with 95% confidence. CCβ must be less than or equal to the MRL for less than 5% of 
noncompliant samples to give a false compliant result.  
To ease the comparison of various methods and their qualification for MRL standards, CCβ has 
been given in Table 4.2 as a fraction of MRL. CC corresponds to limit of quantification and 
CC to limit of detection which were used in assay validation prior to Decision 2002/657/EC 
and determined using various methods. The guidelines for establishing CC and CC in 
Decision 2002/657/EC remove this variation. 
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Table 4.2. An overview of confirmatory methods validated according to Commission Decision 2002/657/EC for macrolide/lincosamide/streptogramin 
(MLS) and/or tetracycline (TC) group antibiotics.  
Analytical 
method 
Sample matrix Sample preparation Sample clean-up  Recovery (%) CCβ (xMRL) Analytes Reference 
UHPLC-
MS/MS 
Chicken muscle LE with 1% acetic acid in ACN/H2O 
(80:20 v/v); LLP by MgSO4 and 
sodium citrate 
Dispersive SPE with PSA 
sorbent; filtration 
75–117  1.1–2 4 M Lopes et al. 
2012 
UHPLC-
MS/MS 
Milk LE with ACN Filtration  58–128 (MLS) n.r. 11 M, 2 L,1 S  Tang et al. 
2012 
HPLC-ESI-
MS/MS 
Animal feed Ultrasonic LE CH3OH/ 
CH3CN/McIlvaine buffer pH 4.6 
(37.5:37.5:25 v/v/v) 
Dispersive SPE with PSA 
sorbent  
51–63 (TC) 
88–109 (MLS) 
n.r. 3 TC 
3 M, 1 L,1 S  
Boscher et al. 
2010 
LC-ESI-
MS/MS 
Fish tissue Ultrasonic LE with ACN/ MeOH 
(1:1 v/v) + 0.05% v/v formic acid 
Filtration  40–100 0.1–0.3 5 TC Dasenaki & 
Thomaidis 
2010 
LC-MS/MS Milk and bovine 
muscle 
Pressurized LE with ASE 200; LE of 
lipids with ether 
Filtration  70–93  1.1–1.6  5M, 2L Juan et al. 
2010 
HPLC-DAD Bovine muscle LE with MeOH/succinic acid buffer 
(1:1 v/v)  
Column MCAC; McIlvaine 
buffer pH 3 elution; cartridge 
SPE; MeOH elution 
91–104  1.2–1.6 4 TC, 3 epi-TC Cristofani et 
al. 2009 
LC-MS/MS Bovine and porcine 
muscle 
LE with MeOH/H2O (7:3 v/v)  - 61–70 (TC) 
75–84 (M) 
1.4–1.9 (TC) 
1.3–1.4 (M) 
4 TC 
4 M 
Granelli et al. 
2009 
HRLC-TOF-
MS 
Muscle (various 
species), fish tissue 
(various species), 
eggs 
LE with ACN/H2O (6:4 v/v) Column SPE; MeOH/ethyl 
acetate (1:1 v/v) elution for egg 
or MeOH/ACN (1:1 v/v) elution 
for muscle and tissue  
63–120 (TC) 
69–261 (ML) 
2 (TC and ML) 4 TC 
6M, 2L 
Peters et al. 
2009 
LC-MS/MS Bovine and porcine 
muscle 
Pressurized LE  with ASE 200 - 73–86 (TC) 
82–91 (ML) 
1.1–1.2 (TC) 
1.1–1.2 (ML) 
3 TC 
4 M, 1 L 
Carretero et 
al. 2008 
UHPLC-ESI-
MS/MS 
Chicken muscle LE with MeOH/H2O (7:3 v/v) Filtration 87–97  1.1–1.2 (TC) 
1.1–1.2 (M) 
4 TC 
4 M 
Chico et al. 
2008  
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Analytical 
method 
Sample matrix Sample preparation Sample clean-up  Recovery (%) CCβ (xMRL) Analytes Reference 
UPLC-TOF-
MS 
Muscle, kidney, 
liver 
LE with ACN/succinate buffer (1:1, 
v/v); LLP with (NH4)2SO4 
Cartridge SPE; elution with ACN 
and ACN/succinate buffer (2:1 
v/v) 
60–148 (TC) 
16–121 (ML) 
1.1–1.4 (TC) 
0.4–1.3 (ML) 
6 TC 
11 M, 5 L 
Kaufmann et 
al. 2008 
UHPLC-TOF-
MS 
Milk LE with ACN Column SPE; MeOH elution n.r. 1.3–1.4 (TC) 
0.3–1.3 (ML) 
4 TC 
6 M, 2 L 
Stolker et al. 
2008 
LC-DAD Liver and kidney  
(various species)  
LE with McIlvaine buffer pH 3.5 Cartridge SPE; MeOH elution 40–88  1.0–1.3  7 M Berrada et al. 
2007 
HPLC-DAD Milk LE with TFA/ oxalate buffer (1:10 
v/v) 
Cartridge SPE; elution with 
CH3OH/CH3CN/0.01 M oxalic 
acid (30:30:40 v/v/v) 
98–111  1.0–1.1  7 TC Samanidou et 
al. 2007 
LC-MS/MS Muscle and kidney 
(various species) 
LE with MeOH/H2O (7:3 v/v) - 26–62 (TC) 
44–104 (M) 
Below MRL 4 TC 
4 M 
Granelli & 
Branzell 2007 
HPLC-DAD Bovine muscle LE with citrate buffer pH 4 Cartridge SPE; elution with 
CH3OH/CH3CN/0.05 M oxalic 
acid (30:30:40 v/v/v) 
91–104  1.1–1.2  5 TC Samanidou et 
al. 2005 
ACN, acetonitrile; ASE 200, accelerated solvent extraction system; epi-TC, 4-epimer metabolite of a tetracycline; HRLC, high-resolution liquid chromatography; LE, liquid extraction; 
LLP, liquid-liquid partitioning; LOD, limit of detection; LOQ, limit of quantification; MCAC, metal chelate affinity chromatography; n.r., not reported; PSA sorbent, primary-secondary 
amine sorbent; PVDF, polyvinylidene difluoride; SPE, solid-phase extraction; TFA, trifluoroacetic acid; TOF, time-of-flight; UHPLC, ultra  high performance liquid chromatography. 
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4.2 Screening methods for antibiotic residues 
 
Screening is used for large sample numbers to pinpoint suspect noncompliant samples to be 
subjected to confirmatory analysis. Methods used for screening can detect an analyte or a family 
at MRL level, and provide semi-quantitative or qualitative results (Cháfer-Pericas et al. 2010). 
Main requirements for a screening method include rapid analysis, ease of use, low set-up and 
running costs, high-throughput capacity, repeatability as well as high sensitivity (low amount of 
false negatives) and specificity (low amount of false positives) (Toldrá and Reig 2006). 
Methods used for screening for antibiotic residues include immunoanalytical methods and 
biosensors, as well as methods typically used for confirmatory analysis (LC-MS, LC-UV/VIS, 
LC-fluorescence, LC-DAD) (Situ and Elliott 2005, Toldrá and Reig 2006, Peters et al. 2009, 
Cháfer-Pericas et al. 2010, Stolker et al. 2010, Verdon 2009). The majority of screening tests is, 
however, based on microbial growth inhibition. In 2001–2003, 15 EU reference laboratories 
reported 53% of muscle sample screening was performed using microbiological methods, and 
the second most common method, ELISA, was used in 21% of cases (Verdon 2009). A 
disadvantage of microbiological assays is that they cannot establish the identity of a compound, 
although they can be fairly group-specific (Pikkemaat et al. 2008, 2009a). However, they are 
cost-effective in situations where the bulk of samples is expected to be compliant (Pikkemaat 
2009). Microbial growth inhibition assays are also suited for high-throughput, require no high-
tech equipment or specialized technicians, and due to their general nature may detect unknown 
or new compounds lacking from the confirmatory method toolkit (Bovee and Pikkemaat 2009). 
Growth-inhibition assays mainly come in two formats: the tube test and the (multi-)plate assay. 
In the tube test, growth of indicator bacteria in the test medium causes a pH-indicator color 
change which is absent during growth-inhibition (Le Breton et al. 2007, Gaudin et al. 2008). 
Simple use and commercial availability of tube tests has caused them to be widely applied both 
in the laboratory and in the field, where residue detection is necessary e.g. because inhibition of 
starter cultures of fermented milk products can cause major economic losses (Mitchell et al. 
1998, Bovee and Pikkemaat 2009). A plate test comprises of an agar plate inoculated with the 
test organism (Ferrini et al. 2006, Gaudin et al. 2010). Diffusion of analyte into the agar causes a 
growth inhibition zone whose diameter is depends on analyte concentration. Detection of all 
veterinary relevant antibiotics requires multi-plate assays with conditions suitable on each plate 
for detection of one or select groups of antibiotics (Pikkemaat et al. 2009b). 
According to European Commission Decision 2002/657/EC, a screening method must have a 
CCβ with a false compliant rate of < 5% (EC 2002b). A guideline document by EU Reference 
Laboratories describes in detail screening method validation through determination of stability, 
applicability and ruggedness, as well as selectivity and specificity (Anon 2010). Stability of the 
analyte and standard samples must be determined under various storage conditions. Applicability 
refers to usability in various sample matrixes, and ruggedness to the method’s ability to 
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withstand minor variations occurring during laboratory analysis, such as age of reagents, 
temperature fluctuations, personnel changes etc. Selectivity and specificity refer to the power of 
discrimination between the analyte and coexisting (related) substances. Table 4.3 presents the 
few microbial screening methods validated along these guidelines. 
Establishment of MRLs and performance criteria of analytical methods (EC 1990, 2002b, 2010a) 
was followed by a critical evaluation of the commonly used screening methods (Pikkemaat et al. 
2008, 2009a, 2011, Gaudin et al. 2010). As Decision 2002/657/EC allows screening method 
development following the validation criteria, national monitoring plans are based on a variety of 
screening methods. The EU Four-Plate Test (EU4pt) (Bogaerts and Wolf 1980) was considered a 
gold standard for a long time, but has now been deemed insufficiently sensitive although it is still 
widely in use (Berendsen et al. 2011). Two commonly used commercial tube tests, Premi® Test 
and Delvotest® SP-NT, lack sufficient detection capability of several antibiotic groups, 
including tetracyclines (Le Breton et al. 2007, Gaudin et al. 2008). In addition, Premi® Test 
suffers from a comparatively high false-positive rate (Pikkemaat et al. 2011).  
Validation of the Screening Test for Antibiotic Residues (STAR) used by the French national 
residue monitoring plan showed the CCβ values of most antibiotics tested, including 
tetracyclines and macrolides/lincosamides, were above the EU MRL values (Gaudin et al. 2004, 
2010). In addition, group specificity was not achieved. Improved group-specificity was attained 
in the six-plate Combined Plate Microbial Assay (CPMA), but false compliant rate of < 5% was 
achieved only partially (Ferrini et al. 2006). The Nouws Antibiotic Test (NAT) used by the 
Dutch national residue monitoring plan yields group-specific detection and shows below- or 
near-MRL sensitivity towards most veterinary antibiotics (Pikkemaat et al. 2008, 2009a). 
However, since initial screening is performed to renal pelvis fluid extracted from kidney, high 
residue levels occurring solely in muscle may never make it to the post-screening step 
(Pikkemaat et al. 2011). NAT has a higher workload due to the extra post-screening step, which 
the CPMA test has been designed to avoid (Ferrini et al. 2006). On the other hand, post-
screening reduces the number of samples subjected to costly confirmatory analysis (Pikkemaat et 
al. 2009a, 2009b).  
The Finnish national monitoring plan uses microbial growth inhibition for the majority of 
screening: out of 6.900 samples tested for the presence of antimicrobials in 2005, 83.6% were 
processed with microbial growth inhibition and 16.4% with physicochemical methods (Saraste et 
al. 2006). For porcine and bovine kidney or muscle samples, a two-plate test was used with 
Bacillus subtilis BGA as the indicator organism, and Delvotest®SP-NT for milk samples. In the 
view of studies discussed above, these methods are not likely to detect all noncompliant samples. 
The widespread use of insufficiently sensitive methods is reflected by a proficiency test 
involving 23 laboratories performing residue screening in the EU (Berendsen et al. 2011). The 
false negative rate for microbial methods was 73% compared to 22% for chemical methods, and 
only 39% of the laboratories identified the test samples correctly.  
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Table 4.3. Microbial growth-inhibition screening methods validated according to CD 2002/657/EC. Detection capability CCβ is 
reported as a fraction of the MRL for only tetracycline (TC) and macrolide/lincosamide (ML) antibiotics. 
Test Test format Indicator organism Analytes Selective conditions 
and supplements 
Sample matrixes CCβ (xMRL) References 
Two-plate 
microbiological 
method 
Multi-plate Bacillus subtilis BGA 
Bacillus subtilis BGA 
TC,Q 
S 
pH 6, NaOH 
pH 7.5, TMP, PABA 
Shrimp 0.28–0.65 (4TC) Dang et al. 
2010 
Screening Test for 
Antibiotic Residues 
(STAR) 
Multi-plate Bacillus subtilis BGA 
Kocuria rhizopila ATCC 9341 
Bacillus cereus ATCC 11778 
Escherichia coli ATCC 11303 
Bacillus stearothermophilus 
ATCC 10149 
TC, AF 
M, C 
TC 
Q, C 
B, S, C, Q, ML, 
AG, AF 
pH 8 
pH 8 
pH 6 
pH 8 
- 
Milk2, muscle 1–2.5 (2TC) 
2 – 5 (2M, 1L) 
Gaudin et 
al. 2010 
Explorer®  Microtiter 
plate 
Geobacillus stearothermophilus S, TC, M, AG - Eggs 7.5–20 (4TC) 
2–2.5 (2M) 
Gaudin et 
al. 2009 
Premi®Test Tube Bacillus stearothermophilus S, TC, M, AG - Eggs 1–10 (4TC) 
0.25–0.5 (2M) 
Gaudin et 
al. 2009 
Nouws Antibiotic 
Test (NAT) 
Post-screening1 
Multi-plate Bacillus cereus ATCC 1178 
Kocuria rhizopila ATCC 9341 
Yersinia ruckeri NCIM 13282 
Bacillus pumilus CN 607 
TC 
B, ML 
Q 
AG 
pH 6, 30 °C 
pH 6, TY, CX, 30 °C 
pH 6.5, 30 °C 
pH 8, 37 °C 
Muscle, kidney 0.25–0.5 (4TC) 
0.07–1 (5M, 2L) 
Pikkemaat 
et al. 2009a, 
2011 
Nouws Antibiotic 
Test (NAT) 
Initial screening1 
Multi-plate Bacillus cereus ATCC 1178 
Kocuria rhizopila ATCC 9341 
Yersinia ruckeri NCIM 13282 
Bacillus pumilus CN 607 
Bacillus subtilis BGA 
TC 
B, ML 
Q 
S,D 
AG 
pH 6, CAP, 30 °C 
pH 8, 37 °C 
pH 6.5, 30 °C 
pH 7, TMP, 37 °C 
pH 8, 37 °C 
Renal pelvis fluid 
 
0.013–0.08 (4TC) 
0.5–4 (5M, 2L) 
Pikkemaat 
et al. 2008 
 
Delvotest® SP-NT Tube Bacillus stearothermophilus B, S, C, AG, TC  - Milk 2 (1TC) Le Breton et 
al. 2007 
AG, aminoglycosides; AF, amphenicols; B, β-lactams; C, cephalosporines; CAP, chloramphenicol; CX, cloxacillin; D, diaminopyridines; M, macrolides; ML, macrolides and 
lincosamides; n.r., not reported; PABA, 4-aminobenzoic acid; Q, quinolones ; S, sulfonamides; TC, tetracyclines; TMP, trimethoprim; TY, tylosin.  
1NAT consists of an initial screening performed to renal pelvis fluid samples, and a corroborating post-screening step for suspect samples using one of the four plates described and 
muscle or kidney fluid as sample.  
2STAR has been validated for milk (Gaudin et al. 2004) following an intralaboratory procedure and not Decision 2002/657/EC criteria. Validation for muscle was done following 
2002/657/EC. 
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5 BIOSENSORS FOR DETECTION OF ANTIBIOTICS IN FOOD 
 
Biosensors are an emerging class of methods suitable for screening purposes. By definition, 
biosensors combine a biological recognition element with a transducer to produce a measurable 
signal proportional to the concentration of the analyte (Velasco-Garcia and Mottram 2003, 
McGrath et al. 2012). Figure 5.1 presents a general working principle of biosensors and the types 
of recognition elements and transducers typically used in biosensors.  
 
 
Figure 5.1. The principle of biosensors. Biosensors combine a biomolecule-based recognition element 
with a transducer, which converts the signal triggered by the recognition event to a quantifiable electric 
signal (Velasco-Garcia and Mottram 2003, McGrath et al. 2012). SPR, surface plasmon resonance; 
WIOS, wavelength-interrogated optical system. 
 
Although biosensors are mostly used for antibiotic detection in the environment, they are also 
increasingly used in screening for antibiotic residues in food, currently in 8% of screening cases 
(Cháfer-Pericas et al. 2010, Reder-Christ and Bendas 2011). Table 5.1 gives an overview of 
biosensors developed for antibiotic detection in food. Biosensor assays have a high capacity for 
automatization and high-throughput, produce results rapidly, and typically require no or very 
simple sample pretreatment (Toldrá and Reig 2006, Huet et al. 2010). Limitations of biosensor 
methods include instability of the biorecognition element due to conditions like pH, ionic 
strength and temperature it is exposed to during immobilization and the assay (Cháfer-Pericas et 
al. 2010). Even so, biosensor methods often are robust enough to allow regeneration, so 
successive cycles of analysis can be performed with the same recognition molecules (Caldow et 
al. 2005, McGrath et al. 2005, Marchesini et al. 2007, Fernández et al. 2009, Adrian et al. 2009). 
Surface plasmon resonance (SPR) appears to be the transducer of choice for antibiotic detection, 
as it is utilized in 49% of published detection methods (Reder-Christ and Bendas 2011). SPR 
allows easy-to-use, real-time, label-free studying of biomolecular interactions (Huet et al. 2010).  
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In accordance with the role of biosensors as an emerging screening tool, a few biosensor 
screening methods have been validated according to 2002/657/EC (Ashwin et al. 2005, Caldow 
et al. 2005, Stead et al. 2011). Biosensor methods are typically suitable only for screening due to 
cross-reactivity within antibiotic groups. However, a biosensor using a ssDNA aptamer as the 
recognition element has been reported to specifically detect tetracycline among tetracycline 
antibiotic family members (Kim et al. 2010). An interlaboratory study compared a SPR 
biosensor screening assay for fluoroquinolones in various food matrices with established 
microbiological growth inhibition and LC-MS/MS methods (Weigel et al. 2009). The study 
demonstrated that unlike the microbiological assay, the biosensor method correctly identified all 
samples and demonstrated advantages in sensitivity and analysis time. However, assay costs 
were higher using the biosensor assay (30–50 €/sample) than the microbiological method (5–15 
€/sample), which may curb the interest in SPR-based biosensor screening methods. 
To establish biosensors as a screening method for antibiotic residues they have been studied in 
combination with confirmatory methods for simultaneous development of a comprehensive 
detection procedure. Ashwin et al. (2005) developed an SPR biosensor screening and LC-
MS/MS confirmatory method for chloramphenicol residues in four different food matrices and 
performed validation of the method according to 2002/657/EC. Marchesini et al. (2007) 
developed a dual SPR biosensor assay, where suspect samples from the first round of SPR are 
subjected to HPLC fractionation, a second round of SPR, and finally LC-ESI-TOF-MS 
confirmatory analysis to identify and quantify residues in positive fractions harboring 
fluoroquinolone receptor binding activity.  
Future directions in antibiotic biosensor development include assay multiplexing and portable 
devices for field use (Huet et al. 2010). As an example of multiplexing, recently developed SPR 
biosensor microarrays simultaneously detect on a single sensor chip two aminoglycoside 
antibiotics or compounds from four major antibiotic families: aminoglycosides, sulfonamides, 
amphenicols, and fluoroquinolones (Rebe Raz et al. 2008, 2009). A biosensor based on a 
wavelength-interrogated optical system (WIOS) transducer can simultaneously detect 
sulfonamide, fluoroquinolone, β-lactam and tetracycline antibiotics on a multianalyte sensor chip 
(Adrian et al. 2009). Portable multiplex SPR biosensors have been developed for on-site analysis 
of milk samples for fluoroquinolone family compounds or sulfonamide, chloramphenicol, and 
fluoroquinolone residues (Fernández et al. 2010, 2011). Commercialization of biosensors 
requires wireless technology, automatization and miniaturization, which also must be future 
directions of antibiotic biosensor development (Luong et al. 2008). 
Proteins, i.e. enzymes and bioreceptors have traditionally been used as biological recognition 
elements in antibiotic biosensors. A new type of recognition element, a DNA-based aptamer was 
recently introduced in tetracycline detection (Kim et al. 2010). Proteins can also be modified for 
improved biosensor performance: a fluorescein-labeled β-galactosidase mutant with reduced 
catalytic activity was used as a recognition element for β-lactams in a fluorescence-based 
biosensor (Chan et al. 2004).     
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Table 5.1. An overview of biosensors for antibiotic detection. The references were chosen on basis of demonstrated applicability in a food matrix 
except Kim et al. (2010) who introduced a new interesting recognition element, a ssDNA aptamer, in antibiotic biosensors. 
Biological recognition 
element 
Recognition 
event 
Tranducer Sample matrix Sample pretreatment Analyte Sensitivity 
(LOD) 
Reference 
DD-carboxypeptidase Inhibition SPR Milk Dilution 7 B 0.5 – 2 x MRL Gustavsson 
et al. 2004 
β-lactamase Hydrolysis Amperometric 
pH detector 
Milk Protein removal by salting-out 1 B 2000 x MRL Chen et al. 
2010 
Polyclonal antibody Binding SPR Honey LLP with potassium buffer/hexane (5:3 
v/v), SPE, MeOH elution 
TY 2.5 μg/kg1 Caldow et 
al. 2005 
Polyclonal antibody Binding SPR Chicken muscle Homogenization, ultrafiltration, clean-
up with SPE, MeOH/ACN (8:2) elution 
6 FQ < MRL Marchesini 
et al. 2007 
Antibody Binding SPR Milk, honey, prawn, 
porcine kidney 
Varies depending on the matrix, 
includes LE, LLP, SPE 
CAP 0.3 – 0.7 x 
MRPL2 
Ashwin et 
al. 2005 
Monoclonal antibody Binding SPR Milk Hydrolysis of the β-lactam ring 9 B ≤ MRL Gaudin et 
al. 2001 
Monoclonal antibody Binding SPR Chicken serum Dilution 8 S 0.07 – 0.2 x 
MRL 
Haasnoot et 
al. 2003 
Monoclonal antibody Binding Bioluminescence Milk - 2 B, 1 C, 2 S, 
3 AG, 2 M 
0.002 – 0.8 x 
MRL 
Knecht et 
al. 2004 
Monoclonal antibody Binding SPR Milk Dilution and filtration 1 FQ, 1 S,      
CAP 
0.02 x MRL 
3.6 x MRPL2 
Fernández 
et al. 2010 
Antibody and receptor Binding WIOS Milk Dilution 1 S,1 FQ, 1 B, 
1 TC 
0.005 – 0.8 x 
MRL 
Adrian et al. 
2009 
Repressor protein Binding SPR Milk, honey Dilution (honey); heating and 
centrifugation (milk) 
7 TC, 3 epi-
TC 
0.15–0.25 x 
MRL 
Moeller et 
al. 2007 
SBP (sulfonamide 
binding protein) 
Binding SPR Porcine muscle Homogenization, liquid extraction 20 S 0.2 x MRL McGrath et 
al. 2005 
ssDNA aptamer Binding Voltammetric Buffer - 1 TC 4 μg/kg Kim et al. 
2010 
Microbial cell Growth 
inhibition 
Potentiometric 
CO2 detector 
Milk - 7 Q, 3 TC 0.25 – 0.8 x 
MRL 
Pellegrini et 
al. 2004 
ACN, acetonitrile; AG, aminoglycosides; B, β-lactams; C, cephalosporines; CAP, chloramphenicol; epi-TC, 4-epimer metabolite of a TC, FQ, fluoroquinolones; LE, liquid 
extraction; LLP, liquid-liquid partitioning; LOD, limit of detection, M, macrolides; MeOH, methanol; Q, quinolones, S, sulfonamides; SPE, solid-phase extraction SPR, surface 
plasmon resonance; TC, tetracyclines; TY, tylosin; WIOS, wavelength-interrogated optical system.  
1No EU MRL for tylosin in honey has been set (EC 2010a) so no detectable residues are allowed. 
2The use of chloramphenicol in treatment of food animals in the EU is prohibited. Therefore, an MRL is not set. The EU minimum required performance limit (MRPL) for 
chloramphenicol residues in food products of animal origin is 0.3 μg/kg (EC 2002b, 2003a). 
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5.1 Whole-cell biosensors 
 
Whole-cell biosensor assays are an emerging bioactivity-based screening method for antibiotic 
residues (Bovee and Pikkemaat 2009). The principle is more widely applied in environmental 
monitoring (Daunert et al. 2000, Köhler et al. 2000, Nivens et al. 2004, Harms et al. 2005, 
Woutersen et al. 2011) but food control applications are increasing (Kurittu et al. 2000a, 2000b, 
2000c, D’Souza 2001, Hakovirta et al. 2006, papers I, III). In whole-cell biosensors, the living 
cell functions as the biological recognition element, which in the event of biosensing produces a 
specific signal to be transduced into a quantifiable electrical signal (Daunert et al. 2000, D’Souza 
2001).  
Whole-cell biosensor bacteria can be divided in systems with constitutive or inducible expression 
(Daunert et al. 2000, Woutersen et al. 2011). The former has a high continuous expression of 
signal, which decreases under toxic conditions (“turn off”). This type of detection is highly 
nonspecific, as signal decrease is a result of any type of cytotoxic effect (Andrew and Roberts 
1993, Vesterlund et al. 2004). Inducible expression, however, is more specific, as transcription 
of the reporter gene occurs only when the stimulus is present (Figure 5.2). Specificity is achieved 
by employing a promoter-regulatory protein pair which recognizes and reacts to the stimulus 
(“turn on”) (Daunert et al. 2000, Su et al. 2011).  
Inducible whole-cell biosensors can be further divided into effect- and compound-specific 
sensors (Daunert et al. 2000, Yagi 2007, Woutersen et al. 2011). The former are stimulated by a 
a change in a physicochemical condition (pH, temperature, osmotic pressure, electron potential) 
or specific type of toxicity (DNA, protein or membrane damage or oxidative stress) by coupling 
the reporter gene to a promoter involved in the stress response (van der Meer et al. 2007, Shapiro  
 
Figure 5.2. Operating principle 
of an inducible bacterial whole-
cell biosensor. The stimulus 
induces reporter gene expression, 
which leads to quantifiable 
signal. Regulatory protein R 
limits induction to occur from 
promoter P only when the 
stimulus is received. Induction 
involves relieving repression or 
activating transcription. 
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and Baneyx 2007). Compound-specific sensors react to a single compound or group of 
compounds with similar chemical characteristics or mode of action (Korpela et al. 1998, 
Wahlström and Saris 1999). Response of the sensor strains correlates with the concentration and 
potency of inducing compounds (Hakovirta et al. 2006, Möhrle et al. 2007). 
Whole-cell biosensor assays offer possibility for more cost-effective and accurate group-specific 
detection than microbial growth-inhibition methods, and are better suited for high-throughput 
due to assay miniaturization from agar plates to microtiter plates (Chafer-Pericas et al. 2010, 
Pikkemaat et al. 2010). Also, growth inhibition on agar plates is typically visualized after 
overnight incubation, whereas whole-cell biosensor assays can be performed within hours 
(Bovee and Pikkemaat 2009, Woutersen et al. 2011). Whole-cell biosensors can equal growth 
inhibition assays in below-MRL sensitivity and simplicity in sample preparation (Pikkemaat et 
al. 2010).  
Biosensor assay ruggedness is advanced by cell preservation methods such as lyophilization, 
vacuum drying, and immobilization in biocompatible polymers (Bjerketorp et al. 2006). These 
methods facilitate reagent-like use of the biosensor cells (Kurittu et al. 2000a, 2000b, 2000c). 
The fact that whole-cell biosensors inherently produce the necessary assay components, and just 
need the presence of the analyte (and sometimes substrate) to induce signal production, further 
enhances assay ruggedness (Su et al. 2011). The renewable storage of assay components within 
the biosensor cell helps overcome instability problems encountered with using purified 
biomolecules such as enzymes as recognition elements in biosensors (Yagi 2007) 
There are, however, some intrinsic disadvantages to using whole-cell biosensors. When purified 
biomolecules are used for recognition, conditions can be optimized for the biosensing event 
(Pellinen et al. 2004, 2006, Weber et al. 2005, Link et al. 2007, Adrian et al. 2009). In contrast, 
biosensor cells continuously sense their local environment, and bioassay variation is caused by 
responses to diverse intra- and extracellular factors such as cell concentration, growth stage and 
metabolic activity, nutrient availability, temperature, pH, oxygen content, inducer type and 
bioavailability as well as duration of induction (Wahlström and Saris 1999, Reunanen and Saris 
2003, Hakovirta et al. 2006, Marqués et al. 2006, Shapiro and Baneyx 2007). However, with 
standardization of assay conditions and applying homogeneous biosensor cell material through 
lyophilization, reproducible results can be achieved (Kurittu et al. 2000a, 2000b, 2000c, 
Smolander et al. 2009).  
Whole-cell biosensors have a narrower detection range than biomolecule-based antibiotic assays 
since toxicity of the analyte to the cell at high concentrations causes a characteristic hook effect 
seen as a bell-shaped dose-response curve (Galluzzi and Karp 2006). Assay conditions must 
therefore be optimized so that the dynamic range of the assay meets the MRL (Kurittu et al. 
2000b, 2000c).  
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Because in biosensor cells the biorecognition elements typically reside within the cell, the 
analyte must first pass the diffusional barrier cell wall – a rate-limiting step in the biosensing 
reaction leading to lowered sensitivity (van der Meer et al. 2004). Utilizing permeabilizing 
agents or host strains with a defective outer membrane permeability barrier can facilitate more 
efficient analyte entry into cell (Möhrle et al. 2007, Kumar et al. 2008). Bacterial cells also have 
group-specific and multidrug mechanisms of antimicrobial resistance, which may hinder 
intracellular accumulation of the antibiotic analyte (Roberts 2003, 2005, 2008, Thaker et al. 
2010). Choosing or creating host strains deficient in antimicrobial resistance mechanisms 
alleviates this problem (Shapiro and Baneyx 2002).  
The choice of reporter gene is yet another factor affecting whole-cell biosensor performance. The 
most commonly used reporters luciferase (bacterial or eukaryotic), green fluorescent protein 
(GFP) and the enzyme β-galactosidase all have their advantages and disadvantages when 
compared to each other (Table 5.2). Light can be measured from bacterial cells non-invasively 
and sensitively, and because of their high sensitivity and fast response times, luciferase reporters 
have found use in numerous biosensors, especially online monitoring systems (Nivens et al. 
2004, van der Meer et al. 2004, Woutersen et al. 2011). GFP and β-galactosidase both suffer 
from a high cellular background. However, they benefit from higher stability compared to 
luciferases and require no ATP for signal production (Köhler et al. 2000, Yagi et al. 2007). 
 
Table 5.2. A comparison of reporter genes and proteins commonly used in whole-cell biosensors. 
Adapted from Daunert et al. 2000, van der Meer et al. 2004, Köhler et al. 2000, Yagi 2007. 
Gene Protein Origin Advantages Disadvantages 
lux Bacterial 
luciferase 
Luminescent 
bacteria 
Rapid response 
High sensitivity 
No exogeneous substrate 
requirement 
Heat lability 
Oxygen and ATP 
requirement 
luc Insect luciferase Firefly, click beetle Rapid response 
Very high sensitivity 
Heat resistance 
Exogeneous substrate 
requirement 
Oxygen and ATP 
requirement 
gfp Green fluorescent 
protein 
Aequorea victoria 
(jellyfish) 
No substrate or ATP 
requirement 
Limited oxygen requirement 
High stability 
Low sensitivity 
Lag time before expression 
Slow maturation 
Autofluorescence 
background 
lacZ β-galactosidase Escherichia coli Detection by naked eye 
Good stability 
No ATP requirement 
 
Exogenous substrate 
requirement 
Modest sensitivity 
Endogenous background 
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5.2 Regulatory elements utilized in whole-cell biosensors  
 
Proteins are intimately involved in control of gene expression in bacteria. There are few 
examples of transcription initiation control mechanisms relying on other molecular classes, such 
as RNA secondary structure-based cis-acting riboswitches (Waters and Storz 2009), but 
transcription initiation is a realm of proteins. For example, approximately 8% (380) of 
Escherichia coli genes are involved in transcription and regulation (Ishihama 2010). The 
majority of these (300) encode DNA-binding and RNA-polymerase binding transcription factors 
which have been divided into 54 families.  
Negative and positive regulators of transcription, i.e. repressor and activator proteins, are applied 
in inducible whole-cell biosensors (Korpela et al. 1998, Wahlström and Saris 1999, Su et al. 
2011, papers I, III). The specific recognition function of these control elements innately 
combines with an activation or derepression function, the effect of which can be seen as 
induction of gene expression. A regulatory protein must specifically bind to a promoter to exert 
its control on transcription (Orth et al. 2000, Schumacher et al. 2002). These regulator-promoter 
pairs act as in vivo regulatory circuits of reporter genes in whole-cell biosensors (Daunert et al. 
2000). The gene regulatory elements used in this study are members of the TetR family of 
transcriptional regulators (TFRs) (papers III, IV) or two-component signal transduction systems 
controlling lantibiotic biosynthesis (papers I, II). Therefore, these two regulatory protein groups 
are introduced more closely. 
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5.2.1 The TetR family transcriptional regulators 
 
Expression of resistance determinants related to TC efflux (see table 3.2) is typically controlled 
by TetR repressors (Agersø and Guardabassi 2005, Brown et al. 2008, Hansen et al. 1993, 
Thaker et al. 2010). As the most well characterized member, TetR gives its name to an entire 
protein family: the TetR family transcriptional regulators (TFRs). TFRs bind to the upstream 
operator region of genes and negatively regulate protein expression by repression (Noguchi et al. 
2000, Orth et al. 2000, Schumacher et al. 2002, Ramos et al. 2005). They are all alpha-helical 
homodimeric proteins with a signal-receiving domain and a DNA-binding domain for 
transduction of the signal (Yu et al. 2010). In addition to antibiotic resistance determinants, 
TFRs control genes whose products are involved in biosynthesis of antibiotics, osmotic stress, 
pathogenicity of gram-negative and gram-positive bacteria, morphogenesis, biofilm formation, 
nitrogen uptake and catabolic pathways such as the citric acid cycle (Ramos et al. 2005, Yu et al. 
2010).  
The DNA-binding structure of TetR is presented in Figure 5.3A. TetR binds tetracycline as a 
TC-Mg
2+
 complex (Kisker et al. 2000, Lederer et al. 1995). The binding of tetracycline to the 
signal-receiving domain of TetR leads to a conformational change that weakens the repressors 
interaction with DNA and results in dissociation from the operator region, which allows efflux 
protein synthesis (Orth et al. 1998, 1999). The 15 bp palindromic tetO operator binds one TetR 
dimer (Orth et al. 2000). Two copies of this operator exist in the intergenic region separating the 
tetR and the divergently oriented tetA gene that codes a TC efflux pump (Ramos et al. 2005). 
TetR binds to these operators and prevents transcription from both promoters. TetR controls 
tetracycline-inducible expression of bacterial luciferase operon (TetR/PtetA::luxCDABE construct) 
in the tetracycline biosensor (Korpela et al. 1998) used in paper III. 
Resistance to macrolide antibiotics is conferred by various mechanisms such as target 
modification, efflux and inactivation (Roberts 2003, 2005, 2008). Macrolide resistance module 
mphR(E)-mph(E)-mrx(E) encodes 2'-phosphotransferase I Mph(E), an inactivating 
phosphorylase, and Mrx(E), a putative hydrophobic transmembrane transport protein 
(Szczepanowski et al. 2007). Expression of these genes is controlled by repressor MphR(E), a 
TFR. In paper IV, structural and functional characterization of MphR(E) was based on a 
homology model built using the structure of a related protein MphR(A) (Figure 5.3B) as a 
reference. The entire macrolide resistance operon mphR(E)-mph(E)-mrx(E) is related to 
resistance module mph(A)-mrx(A)-mphR(A) with genes sharing sequence identity (34–40%) and 
identical functions (O’Hara et al. 1989,  Noguchi et al. 1995, 2000). MphR(A) binds a 35 bp 
promoter upstream from mph(A) (Noguchi et al. 2000), whereas MphR(E) controls expression 
from a 52 bp promoter upstream from mph(E) (Szczepanowski et al. 2007). Degenerated 
palindromic motifs of 26 bp reside within promoters of both MphR(E) and MphR(A). They are 
similar in length to qac operator, which binds two QacR dimers for repression (Schumacher et 
al. 2002). Therefore, it is possible that two MphR repressors bind per operator.  
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Figure 5.3. Structures of TFRs TetR and MphR(A). A) TetR in complex with operator DNA (PDB 
accession code 1QPI, Orth et al. 2000). The two TetR monomers are shown in cyan and magenta, and 
DNA strands in grey and pink. DNA binding domains sit in the major groove of operator DNA when the 
repressor is in the uninduced state i.e. not bound to ligand. B) MphR(A) in complex with two 
erythromycin ligands (PDB accession code 3FRQ, Zheng et al. 2009). The two MphR(A) monomers are 
shown in blue and green, and erythromycins in black. Two chloride ions modeled in proximity of the 
ligand binding sites are shown in orange. In MphR(A), ligand binding causes a structural change which 
increases the distance of the two DNA binding domains by 3.4 Å, and leads to induced state and 
dissociation from DNA. Images were created with UCSF Chimera (Pettersen et al. 2004; 
http://www.cgl.ucsf.edu/chimera/). 
 
  
A) B) 
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5.2.2 Nisin biosynthesis gene cluster regulators 
 
The lantibiotic biosynthesis operons generally contain genes coding for the prepeptide (lanA), 
enzymes responsible for the modification reactions (lanBCM), processing proteases for removal 
of the leader peptide (lanP), regulatory proteins (lanRK), an ABC superfamily transport protein 
involved in translocation (lanT), and immunity proteins (lanIFEG) (Chen and Hoover 2003). The 
biosynthesis, regulation and immunity machinery responsible for nisin production is presented in 
Figure 5.4. Lantibiotic gene clusters may be chromosomal or present on plasmids. The nisin gene 
cluster is located on chromosomal conjugative transposons such as Tn5276, Tn5301, Tn5306, 
and Tn5307 (Horn et al. 1991, Thompson et al. 1991, Lubelski et al. 2008).  
Two component systems (TCSs) are the chief mechanism used by bacteria for sensing their 
environment (Rodrigue et al. 2000). Most species contain more than a dozen TCSs that regulate 
processes such as metabolism, motility, osmoregulation, transport, virulence and development 
(West and Stock 2001, Gao and Stock 2009). The signaling pathways defined by TCSs consist of 
four steps. A homodimeric sensor histidine kinase is autophosphorylated by ATP at a histidine 
residue (Casino et al. 2009). The phosphoryl group is then relayed to an aspartate on a cognate 
response regulator which then interacts with DNA, RNA or protein targets, triggering cellular 
responses (Gao and Stock 2009). Finally, signaling is terminated by dephosphorylation by an 
intrinsic or histidine kinase -induced autophosphatase activity (Casino et al. 2009).  
The expression of genes nisABTCIPRK and nisFEG under their respective promoters nisA and 
nisF is controlled by nisin itself via the two-component system NisRK (Lubelski et al. 2008). 
The membrane kinase NisK autophosphorylates upon interaction with extracellular nisin, and 
phosphorylates the activator NisR, which then induces transcription from PnisA and PnisF (Figure 
5.4). The NIsin-Controlled gene Expression system (NICE) exploits nisin mediated auto-
induction to facilitate efficient over-expression of genes (Kuipers et al. 1998, Mierau and 
Kleerebezem 2005). The system consists of Lactococcus lactis host strains expressing nisRK 
genes, and plasmids containing the nisA or nisF promoter fragments, followed by convenient 
cloning sites to introduce the gene(s) of interest. NICE has been used for expression of a 
multitude of homologous and heterologous proteins of both Gram-positive and Gram negative 
origin even in an industrial scale (Mierau and Kleerebezem 2005, Zhou et al. 2006). Since the 
NICE system is extremely tightly controlled and provides a linear dose–response relationship, it 
was an ideal host system to be used in construction of the bioluminescent nisin biosensor strain 
in paper I. 
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Figure 5.4.  Biosynthesis, regulation and immunity machinery responsible for nisin production. In the 
nisin gene cluster, nisA is the structural gene, nisBTCP are involved in modification, translocation and 
processing, nisIFEG in immunity and nisRK in regulation. Extracellular changes in nisin concentration 
result in autophosphorylation of NisK and transfer of a phosphoryl group from NisK to an aspartate 
residue on NisR. The activated NisR then induces transcription of nisABTCIPRK and nisFEG. In the 
absence of extracellular nisin, nisI and nisRK are expressed from independent nisI and nisR promoters. 
NisA is processed by a dehydratase (NisB) and cyclase (NisC) multienzyme complex to generate the 
lanthionine rings in the mature polycyclic peptide. The peptide is then transported out of the cell by NisT 
in an ATP-dependent manner, and the leader sequence is removed by the membrane-anchored protease 
NisP to generate the active antimicrobial agent. NisI and NisFEG are involved in producer self-protection. 
NisI sequesters nisin to reduce its concentration while NisFEG forms an ABC transporter complex to 
extrude nisin from the membrane to the extracellular environment. Adapted from Patton and van der 
Donk 2005, Lubelski et al. 2008. 
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5.3 Inducible whole-cell biosensors for antibiotic detection 
 
Inducible whole-cell biosensors for antibiotics include effect-specific and compound-specific 
sensors (Table 5.3). Effect-specific biosensors are induced by a stress reaction caused by the 
mechanism of action of different antibiotic classes. A panel of Escherichia coli based biosensors 
includes strains induced by cold shock response to translation inhibition (cspA promoter; 
amphenicol and tetracycline antibiotics), heat shock response to translation inhibition (ibp; 
aminoglycosides), SOS response to DNA replication inhibition (sulA; quinolones) and heat 
shock response to membrane damage and peptidoglycan synthesis interference (P3rpoH; β-
lactams, polymyxins) (Bianchi and Baneyx 1999, Shapiro and Baneyx 2002, 2007). A similar 
system based on Bacillus subtilis whole-cell biosensors responds to antibiotic interference of the 
five major biosynthetic pathways of bacteria: biosynthesis of DNA, RNA proteins, cell wall, and 
fatty acids (Hutter et al. 2004a, Urban et al. 2007). The antibiotic-inducible promoters were 
found by analyzing upregulated genes in an expression profile database of B. subtilis 168 (Hutter 
et al. 2004a, 2004b) and therefore the regulatory proteins and pathways are not known.  
Effect-specific biosensors can be used in seeking entirely new antibiotic mechanisms of action: 
bacterial cell division inhibiting compounds were discovered with a B. subtilis biosensor 
featuring two reporter genes to facilitate differentiation of specific and nonspecific inhibitors 
(Stokes et al. 2005). A downside of effect-specific biosensors regarding antibiotic residue 
detection is that they can detect analytes other than antibiotics that induce the same effect. For 
example, DNA damaging agent-detecting SOS response biosensors are also induced by 
substances like formaldehyde and hydrogen peroxide (Norman et al. 2005, Biran et al. 2011).   
Compound-specific biosensors for antibiotics offer more specific identification (Table 5.3). 
These whole-cell biosensors typically detect analytes in a group-specific manner, i.e. are 
responsive to a group of structurally similar antibiotics instead of a single compound. This kind 
of behavior is an advantage in screening as all or several compounds of an antibiotic family can 
be detected simultaneously (van der Meer et al. 2004). Several TetR-based tetracycline-specific 
whole-cell biosensors have been constructed (Table 5.3). Some of these have also been applied 
for TC detection in a food matrix. Hansen and Sørensen (2000) demonstrated applicability of a 
β-galactosidase-expressing biosensor in TC detection in incurred milk samples, whereas the 
bioluminescent biosensor by Korpela et al. (1998) has been applied in milk (Kurittu et al. 2000b, 
2000c), porcine serum (Kurittu et al. 2000a), fish tissue (Pellinen et al. 2002), and poultry tissue 
samples (Pikkemaat et al. 2010, paper III). 
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Table 5.3. An overview of effect- and compound-specific inducible whole-cell biosensors for antibiotics.  
Type Analyte Effect/Regulatory 
protein 
Promoter Reporter 
gene(s) 
Host Limit of 
detection1 
Induction 
time 
Remarks Reference 
Effect-
specific 
Fluoro-
quinolones 
DNA replication 
interference 
pL luxCDABE E. coli n.d. 60–90 min Heat induces pL  reporter 
plasmid replication, whose 
inhibition decreases signal. 
Anko et al. 
2002 
 DNA damaging 
agents 
SOS response cda  
recA 
sulA 
umuDC 
gfp E. coli n.d. 90–120 
min 
 Norman et 
al. 2005 
 Different 
antibiotic 
classes 
Translation inhibition 
DNA replication 
interference 
cspA 
sulA 
lucFF 
lucR1 
E. coli 1000 CAP 
50 OFL 
3 h Dual reporter strain cspA::lacZ 
sulA::lucR1 detected both effects. 
Shapiro and 
Baneyx 
2007 
 Vast majority of 
antibiotic 
classes 
DNA biosynthesis 
RNA biosynthesis 
Protein biosynthesis 
Cell wall biosynth. 
Fatty acid biosynth. 
yorB 
yvgS 
yheI 
ypuA 
fabHB 
lucFF B. subtilis n.d. 3 h 
90 min 
4 h 
1 h 
3 h 
The panel targets the majority of 
antibiotic classes. However, e.g. 
aminoglycosides did not induce 
yheI. 
Urban et al. 
2007 
 Different 
antibiotic 
classes 
DNA damage 
Heat-shock 
Quorum sensing 
recA 
grpE 
lasI 
luxCDABE E. coli 50–5x105 n.r. Response signature of growth 
and/or luminescence inhibition 
and induction indicates mode of 
action. 
Eltzov et al. 
2008 
  -lactams, 
glycopeptides 
D-cycloserine, 
bacitracin 
Cell wall stress pbp2 
tcaA 
vraSR 
sgtB 
lytR 
lacZ S. aureus n.d. 2 h  Steidl et al. 
2008 
 DNA damaging 
agents 
SOS response sulA phoA E. coli 50 MMC 
1700 NA 
2 h Sensitivity-enhancing host 
knockout mutations: enhanced 
cell membrane perme-ability 
(rfaE), inhibited DNA damage 
repair (umuD, uvrA). 
Biran et al. 
2011 
Compound-
specific 
Tetracyclines TetR tetA luxCDABE E. coli 6 90 min  Korpela et 
al. 1998 
 Tetracyclines TetR tetA lacZYA 
luxCDABE 
gfp 
E. coli 
 
 
10 
< 10 
< 20 
3 h 
50 min 
16 h 
 
 
 
Hansen and 
Sørensen 
2000 
 Tetracyclines TetR tetA gfp E. coli 50  16 h FACS-optimized GFP mutant. Hansen et 
al. 2001 
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Type Analyte Effect/Regulatory 
protein 
Promoter Reporter 
gene(s) 
Host Limit of 
detection1 
Induction 
time 
Remarks Reference 
Compound-
specific 
Tetracyclines TetR tetA gfp E. coli 5-16 18 h Extended range biosensor created 
by insertion of tet(M) resistance 
gene. 
Bahl et al. 
2005 
 Tetracyclines TetR tetA lacZ 
nuoA 
selA 
E. coli 110 
2.6 
1450 
2 h Amperometric detection of cell 
respiration which is affected by 
expression of reporter genes. 
Song et al. 
2012 
 Macrolides MphR(A) mphA luxCDABE E. coli 0.008 2 h  Möhrle et 
al. 2007 
 Vancomycin VanRS vanH lacZ B. subtilis 100–1000 4 h Also responsive to other glyco-
peptides, -lactams, D-cyclo-
serine, bacitracin, fosfomycin.  
Ulijasz et al. 
1996 
 -lactams AmpR ampC luxCDABE E. coli 2.5–2500 3 h  Valtonen et 
al. 2002 
CAP, chloramphenicol; gfp, green fluorescent protein gene; FACS, fluorescence-activated cell sorting; lacZYA, lac operon encoding β-galactosidase (lacZ), β-galactoside 
permease (lacY) and β-galactoside transacetylase (lacA); lucFF, Photinus pyralis firefly luciferase gene; lucR1, a red-shifted variant of firefly luciferase; luxCDABE, 
Photorhabdus luminescens or Vibrio fischeri bacterial luciferase operon encoding luciferase (luxAB) and fatty acid reductase complex (luxCDE); MMC, mitomycin C; n.d., not 
determined, NA, nalidixic acid; nuoA, NADH dehydrogenase I subunit A gene; OFL, ofloxacin; phoA, alkaline phosphatase gene; selA, selenocysteine synthase gene. 
1In ng/ml. For effect-specific biosensors, limit of detection is not relevant since multiple classes of antibiotics cause induction with various potencies. 
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6 NISIN DETECTION METHODS 
  
Nisin is approved as a food preservative in over 80 countries, and it is used particularly in 
processed cheese, dairy products and canned foods (Delves-Broughton et al. 1996, Delves-
Broughton 2005, Gálvez et al. 2011). Nisin is not, however, considered natural when it is applied 
in concentrations that exceed what is found in food naturally fermented with a nisin-producing 
starter culture. Various countries have set maximum levels of nisin in foods (Cleveland et al. 
2001). Therefore, several methods for nisin detection and quantification have been developed. In 
the EU, Directive 95/2/EC sets a maximum level of 3–12.5 mg/kg for nisin in various foodstuffs 
(EC 1995). An ISO standard for the determination of the nisin A content in cheese by LCMS and 
LCMS/MS has also been published (ISO 2009).  
An overview of nisin detection methods is presented in Table 6.1. A growth-inhibition-based 
agar diffusion assay originally introduced in 1964 for nisin detection is still widely in use 
(Tramer and Fowler 1964, Fowler et al. 1975). Although improved versions of the assay have 
been developed (Wolf and Gibbons 1996, Pongtharangkul and Demirci 2004), several 
parameters such as sample diffusion properties, choice of indicator organism and assay media as 
well as subjectivity in determining inhibition zone size affect the sensitivity and accuracy of this 
method. Consequentially, alternative methods for nisin detection and quantification have been 
devised. These include physico-chemical methods based on capillary zonal electrophoresis 
(Rossano et al. 1998), micellar electrokinetic chromatography (Soliman and Donkor 2010), LC-
MS/MS (Schneider et al. 2011), immunochemical methods (Suárez et al. 1996, Bouksaim et al. 
1998, Daoudi et al. 2001, Aly et al. 2011) and microbiological methods such as turbidometric 
bioassays (Turcotte et al. 2004) and flow cytometry (Budde and Rasch 2001). Not all methods 
utilize food samples, but nisin standards diluted in buffer. 
Most sensitive nisin detection and quantification is, however, achieved by nisin-inducible whole-
cell biosensor assays. The whole-cell biosensor assays based on nisin-inducible bioluminescence 
(Wahlström and Saris 1999, paper I) and fluorescence (Reunanen and Saris 2003, Hakovirta et 
al. 2006) involve reporter genes encoding luciferase (luxAB or luxABCDE) or green fluorescent 
protein (gfp) placed under control of a nisin-inducible promoter. Maturation of fluorescent 
reporter proteins takes longer than luciferase enzyme maturation, and sensitivity is typically 
lower in fluorescent whole-cell biosensors due to interfering background autofluorescence 
(Hakkila et al. 2002). These effects were seen in fluorescent nisin biosensor assays, which 
required overnight incubation and removal of light-absorbing supernatant from assay wells prior 
to fluorescence measurement. Bioluminescent nisin sensors offer the most sensitive nisin 
detection ever obtained (paper I). 
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Table 6.1. An overview of nisin quantification methods for food samples.  
Category Method Analyte1 Sample matrix Sample pretreatment LOD  Recovery 
(%) 
Reference 
Physico-
chemical 
Capillary 
electrophoresis 
Nisin Milk Nisin spiking, dilution, ACN 
extraction, centrifugation, 
suspension and filtration 
10.000 μg/l n.d. Rossano et al. 
1998 
 Micellar 
electrokinetic 
chromatography 
Nisin Milk, cream, yogurt, 
yogurt drink, processed 
cheese, beer, wine, salad 
dressing, canned tomatoes 
Homogenization, (ultra)filtration, 
centrifugation, nisin spiking 
300–800 μg/l 90–104 Soliman and 
Donkor 2010 
 LC-MS/MS Nisin A, Z Processed cheese Dilution, homogenization, acid 
extraction by heating, 
centrifugation and filtration 
n.d. (at least 50 
μg/l) 
49–69 Schneider et al. 
2011 
Immuno-
chemical 
Immunoblot assay Nisin Z Milk and whey Nisin spiking, dilution, EDTA 
and Triton X-100 addition, 
heating, dilution 
155 μg/l n.d. Bouksaim et al. 
1998 
 Competitive ELISA  Nisin Z Milk and whey Nisin spiking, acidification, 
heating, centrifugation, filtration 
91–106 μg/l 89–98 Daoudi et al. 2001 
 Competitive ELISA Nisin  Cheese Dilution, homogenization, 
centrifugation 
626 μg/kg 98–120 Aly et al. 2011 
Micro-
biological 
Growth inhibition 
(agar diffusion) 
Nisin Nisin-containing food 
material (not specified) 
Dilution, homogenization, acid 
extraction by heating, 
centrifugation and filtration 
< 30.000 μg/l n.d. Fowler et al. 1975 
Biosensor Bioluminescent 
whole-cell 
Nisin Milk Nisin spiking 0.075 μg/l n.d. Wahlström and 
Saris 1999 
 Fluorescent whole-
cell 
Nisin Milk, processed cheese, 
salad dressing 
Nisin spiking, dilution 45–1000 μg/kg n.d. Reunanen and 
Saris 2003 
 Fluorescent whole-
cell 
Nisin Milk, processed cheese, 
salad dressing, canned 
tomatoes, liquid egg 
Nisin spiking, dilution 0.2 –9 μg/kg n.d. 
 
Hakovirta et al. 
2006 
 Bioluminescent 
whole-cell 
Nisin Milk Nisin spiking, dilution 0.003 μg/l 25–36 Paper I 
ACN, acetonitrile; ELISA, enzyme-linked immunosorbent assay; n.d., not determined; LOD, limit of detection. 
1When only nisin is indicated as the analyte, the study did not take into account detection efficiency of nisin variants. 
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7 AIMS OF THE STUDY 
 
This study aims to develop rapid, sensitive, inexpensive and simple whole-cell biosensor based 
methods for screening for antimicrobial residues and producers of antibiotic molecules. These 
methods can be applicable in a variety of sample matrices such as different foodstuffs. 
Recognition of the presence of the analyte in the sample induces bioluminescence production 
within the biosensor cells. Assay simplicity is underlined by no need to add exogenous 
substrates, as the enzyme and substrate needed for the bioluminescence reaction are produced 
endogenously within the biosensor cells. Furthermore, the reagent-like use of biosensor cells in a 
lyophilized form removes the need to culture them separately for each assay. 
Tetracyclines are the most commonly used class of veterinary antibiotics (Grave et al. 2010). 
This study involved assessing the functionality of a previously developed TetR repressor protein 
regulated tetracycline biosensor (Korpela et al. 1998) in screening for tetracycline residues in 
poultry muscle. Simultaneously, the effects of various tetracyclines and tetracycline metabolites 
in the biosensor assay were determined.  
Nisin is an antimicrobial peptide naturally produced by some Lactococcus and Streptococcus 
strains. The use of nisin as a food preservative is limited by the EU to 3–12.5 mg/kg in various 
food products (EC 1995), placing a demand for effective and sensitive nisin assays. A nisin-
specific biosensor strain was constructed and used in this study for detection, quantification and 
screening purposes.  
Macrolides are the fourth most used group of veterinary antimicrobial agents in the EU (Grave et 
al. 2010). A novel macrolide-specific repressor protein MphR(E) (Szczepanowski et al. 2007) is 
a candidate for development of macrolide-responsive biosensors. In the first ever study on 
MphR(E) structure and function, we analyzed and sought to modify DNA binding characteristics 
of the repressor protein to improve its performance as a biosensor regulatory element.  
Specific aims for the study: 
• Construction of a nisin biosensor, and its use in detection of nisin in food samples (I) 
• Utilization of the nisin biosensor in screening for nisin producers in food samples (II) 
• Development of a screening method for tetracycline and their 4-epimer metabolite 
residues in poultry meat and comparison with a microbiological growth inhibition 
assay (III) 
• Studying the structure-function relationships of the macrolide specific repressor 
protein MphR(E) and developing improved versions of the repressor for biosensor 
use by rational mutagenesis (IV)  
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8 MATERIALS AND METHODS 
 
8.1 Bioluminescent biosensor organisms (I, II, III) 
 
The bioluminescence reaction of bacteria [1] involves the oxidation of reduced riboflavin 
phosphate (FMNH2) and a long-chain aldehyde conjoined with emission of blue-green light 
(Meighen 1991). 
FMNH2 + RCHO + O2  FMN + H2O + RCOOH + hν (490 nm)   [1] 
On bacterial luciferase operons, the luciferase enzyme performing the oxidation reaction is coded 
by luxAB, and the fatty acid reductase complex responsible for synthesizing the fatty aldehyde 
substrate by luxCDE (Meighen 1993). Paper III used a tetracycline biosensor strain (Korpela et 
al. 1998) harboring a sensor plasmid that contains bacterial luciferase operon luxCDABE from 
Photorhabdus luminescens (Meighen and Szittner, 1992). In papers I and II, we used a modified 
version luxABCDE of the P. luminescens luciferase operon that has been altered to be functional 
in Gram-positive bacteria (Francis et al. 2000). The structures of the sensor plasmids used in I, II 
and III and the regulated bioluminescence response pathways are described in Figures 8.1 and 
8.2. 
 
 
Figure 8.1. Sensor plasmids used in this study. A) The tetracycline biosensor used in paper III had been 
constructed by transforming the host strain E. coli K-12 M72 [Sm
R
lacZ(Am)Δbio-
uvrBΔtrpE42(λN7(Am)N53(Am)cI857-ΔH1)] with pTetLux1 (Korpela et al. 1998). The plasmid contains 
a gene encoding the repressor protein TetR, which controls transcription from tetA promoter. B) Plasmid 
pNZ8048 was constructed in paper I for use as a sensor plasmid in host strains L. lactis NZ9800 and 
NZ9000 (Kuipers et al. 1993, 1998). The two resulting biosensor strains were denoted NZ9800lux and 
NZ9000lux.  
A) B) 
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Figure 8.2. Regulation of bioluminescence response pathways in the whole-cell biosensors used in this 
study. A) All biosensing elements of the tetracycline biosensor are present on the same plasmid. 
Repression of luxCDABE transcription by TetR is lifted in the presence of TC molecules. This results in 
expression of the luciferase enzyme and concomitant bioluminescence. B) Nisin-induced expression of 
luciferase requires regulatory protein genes nisRK of the host chromosome (Mierau and Kleerebezem 
2005). NisK is a histidine kinase present at the cytoplasmic membrane. Upon nisin binding, it activates 
the response regulator NisR through phosphorylation, and luxABCDE expression is induced from nisA 
promoter. 
 
 
8.2 Cultivation and lyophilization of biosensor cells (I, II, III) 
 
For use in bioassays, E. coli K-12(pTetLux1) was cultivated in Luria-Bertani broth (LB) 
supplemented with 100 μg/ml ampicillin (III), and NZ9800lux and NZ9000lux in M17 broth 
(Terzaghi and Sandine 1975) supplemented with 0.5% w/v glucose and 10 μg/ml 
A) 
 
 
 
 
 
B) 
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chloramphenicol (M17GCm) (I, II). The biosensors were used in the bioassays either as freshly 
cultivated or reconstituted lyophilized cells. Lyophilization was performed with cells grown to 
late logarithmic phase, which were then harvested and suspended in LB or M17G supplemented 
with 10% lactose. The cell suspension was distributed in glass vials and lyophilized under 
vacuum following a 24 h (III) or 96 h (I) procedure (Sidyakina and Golimbet 1991). 
Reconstitution of biosensor cells was performed by adding fresh medium in the vial and 
incubating at room temperature.  
 
8.3 Sample preparation for biosensor assays (I, II, III) 
 
A nisin preparation containing 2.5% nisin in milk solids and NaCl was used as standard material 
in the nisin bioassays (I). The powder was dissolved in 0.1% Tween 80. Nisin standards were 
prepared as serial dilutions in 0.1% Tween 80 or low-fat milk. To identify nisin producers, 
samples collected from culture media of lactococci were serially diluted in 0.1% Tween 80 and 
compared to nisin standards in a nisin biosensor assay. 
To screen for nisin producers (II), raw milk was diluted in peptone water and plated on M17G 
agar supplemented with 1% w/v lactose (M17GL). Mixed and isolated cultures of raw milk lactic 
streptococci were used as sample material. A panel of 91 Lactococcus strains was cultured on 
M17GL prior to screening. Bacteriocin producers tested in the screening assay were cultured on 
media suitable for each species. To characterize the bacteriocin produced by strain SL149, a 
sample of its culture medium and a nisin-containing sample were run on a sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel and subjected to a nisin bioassay. 
Tetracycline-spiked poultry meat fluid was used as sample material in the tetracycline assays 
(III). Organically produced chicken meat was spiked with TC parent compounds, 4-epimer 
metabolites, or H2O to obtain blank material. After mincing and incubating to obtain uniform 
antibiotic distribution, the meat was heated at 64 °C and centrifuged to collect the resulting fluid. 
 
8.4 Characterization of nisin producers (II) 
 
Nisin producers identified using a nisin biosensor overlay were characterized by PCR 
amplification and sequencing of the 16s rRNA and nisin genes (II). In addition, his operon 
amplification product length and genetic fingerprinting by repetitive BOX element sequence-
based PCR (BOX-PCR) and random amplified polymorphic DNA (RAPD) were used for 
characterization. 
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8.5 MphR(E) repressor protein expression and mutation (IV) 
 
In paper IV, MphR(E) gene was PCR-amplified from plasmid pUC18-mphR(E)-mph(E)-mrx(E) 
(Szczepanowski et al. 2007) and inserted into plasmid pAK400c (Santala and Lamminmäki 
2004). The primers used added an N-terminal 6 x histidine tag and a tobacco etch virus (TEV) 
protease site to facilitate tag removal. Rational design of mutations was based on a 3D model of 
MphR(E) built with Swiss-pdbViewer v4.0.3 (Guex and Peitsch 1996, 1997) using the crystal 
structure of a related protein, MphR(A) (Zheng et al. 2009), as a template. Mutations were 
introduced into mphR(E) by gene splicing overlap extension PCR (SOE-PCR) using mutagenic 
primers designed for each individual mutation. 
MphR(E) expression was performed in E. coli XL1-Blue by an overnight IPTG-induction of 
cells cultured to late logarithmic phase. The protein was purified with Ni-NTA affinity 
chromatography and digested with TEV protease obtained from expression plasmid pMHT238Δ 
(Blommel and Fox 2007) harboring strain E. coli DH5. Protein purity and success of digestion 
were verified by SDS-PAGE and mass spectrometry. 
 
8.6 Bioluminescence and fluorescence anisotropy data collection and analysis          
(I, II, III, IV) 
 
Bioluminescence signal from whole-cell biosensor assays was read with multidetection 
microplate readers: Plate CHAMELEON
TM
 (Hidex) in paper I, and Synergy HT (BioTek 
Instruments Inc.) in paper III. The screening application in paper II utilized in vivo 
bioluminescence imaging by Xenogen IVIS Lumina II (Caliper Life Sciences) to detect nisin 
production-indicating bioluminescence.  
Induction coefficients (IC) (in paper I referred to as induction factor, IF) were calculated (I, III) 
from bioluminescence data using equation 2:  
IC = 
  
  
                                            [2] 
where BS is the measured bioluminescence signal in relative light units (RLU) from a sample and 
BB the measured bioluminescence signal in relative light units (RLU) from a blank sample 
containing all assay components except the analyte. 
Limit of detection was determined in paper I as the concentration of nisin at which the IC 
exceeded the value two. In paper III, the limit of detection was the tetracycline concentration at 
which the IC exceeded the value three. 
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In paper IV, fluorescence anisotropy was used to determine dissociation constant (Kd) of the 
interaction of MphR(E) wild type or mutant protein with fluorescently labeled Pmph-mrx promoter 
DNA. Data was obtained with Plate CHAMELEON
TM
 equipped with polarizing excitation and 
emission filters and fit into equation 3:  
               
           √                 
    
                   [3] 
Where A = the experimental anisotropy; Af = the anisotropy for the free ligand; Ab = the 
anisotropy for the fully bound ligand; LT = the total added concentration of ligand; RT = The 
total added concentration of receptor. The ligand is the fluorescein-labeled promoter DNA, and 
the receptor the MphR(E) repressor. 
 
8.7 Mass spectrometry experiments (IV) 
 
In paper IV, mass spectrometric experiments were performed with a 12-T hybrid quadrupole 
Fourier transform ion cyclotron resonance (FT-ICR) instrument (Apex-Qe™; Bruker Daltonics, 
Billerica, MA, USA) equipped with an Apollo-II (Bruker) electrospray ionization (ESI) source. 
Prior to mass measurements, all protein samples were desalted by buffer exchanging to 10 mM 
ammonium acetate pH 6.9 and concentrated if necessary. Mass spectra were measured using 
either denaturing solvent conditions (acetonitrile/water/acetic acid, 49.5:49.5:1.0, v/v) or native 
conditions (500 mM ammonium acetate pH 7.0). To study ligand binding, a small aliquot of the 
protein sample was mixed with a ligand to obtain 1:1 or 1:2 molar ratios with respect to 
monomeric protein and directly measured.             
  
55 
 
9 RESULTS AND DISCUSSION 
 
9.1 Biosensor assay protocols (I, II, III) 
 
A biosensor assay in 96-well format was developed for nisin (I) and tetracyclines (III). Figure 
9.1 presents the final, optimized assay protocols. Both assays utilized lyophilized biosensor cells 
as a reagent-like component, making assay execution rapid and simple. Samples and standards 
were dispensed on the plate along with the biosensor cells for bioluminescence induction.  Total 
assay durations were three (I) and four (III) hours, including sample preparation during cell 
reconstitution. As the biosensors utilized P. luminescens bacterial luciferase operon, the long-
chain fatty aldehyde substrate is synthesized innately within the biosensor cells, and no addition 
of exogenous substrate was therefore required in the assay. The nisin biosensor constructed in 
paper I was utilized in paper II to develop a rapid and simple plate overlay assay for screening 
for nisin producers in mixed cultures of food sample bacteria, or isolated cultures of putative 
nisin producers (Figure 9.2). The assay produced results within one hour of application of the 
overlay.  
The biosensor assay for nisin (I) is simple to perform compared to other nisin quantification 
methods presented in Table 6.1. There is minimal sample pretreatment involved, only dilution 
with an acidic, detergent containing solution. The protocols of the other nisin whole-cell 
biosensor assays require addition of an exogenous substrate (Wahlström and Saris 1999) or 
overnight induction and a complex medium removal and freeze-thaw treatment before signal 
measurement (Reunanen and Saris 2003, Hakovirta et al. 2006).  
Exogenous substrate additions are a source of assay variation due to flash kinetics of the 
bacterial bioluminescence reaction (Meighen and Hastings 1971). Bioluminescence 
measurement from each sample should be performed with an identical delay after substrate 
addition, but in practice this is difficult to carry out. The assay by Wahlström and Saris (1999) 
did not utilize lyophilized cells, which may cause growth-stage related variance in luciferase 
expression (Galluzzi and Karp 2007). The biosensor assays based on green fluorescent protein 
reporter (Reunanen and Saris 2003, Hakovirta et al. 2006) use end-point analysis of fluorescence 
signal from stationary phase cells, and therefore are not affected by growth stage. However, GFP 
reporter matures slowly and therefore requires an overnight incubation (Hakkila et al. 2002). 
GFP-based assays are also less sensitive than luciferase assays due to background 
autofluorescence and relatively low fluorescence intensity (Daunert et al. 2000). These 
properties are a drawback to using these biosensors in nisin producer identification, as substrate 
additions and overnight incubations would complicate the simple overlay assay protocol 
developed in paper II. Hu et al. (2009) also used a biosensor based on the NICE system (see 
chapter 5.2.2) in identification of nisin producers. However, their assay included using culture 
supernatants of putative nisin producers as samples, and an SDS-PAGE analysis to detect 
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expression of reporter protein. The overlay assay (II) does not require pure cultures, but instead, 
nisin producers can be identified within mixed cultures. The bioluminescence signal can be 
recorded directly from the plate, and no separate detection assay is needed.  
In addition to poultry muscle (III), the tetracycline biosensor has been applied for milk (Kurittu 
et al. 2000b, 2000c), porcine serum (Kurittu et al. 2000a), and fish tissue samples (Pellinen et al. 
2002). All these assays include simple sample pretreatment, and the assay is performed using 
lyophilized sensor bacteria in buffered media and in the presence of a chelating agent. In paper 
III, the assay was further sensitized with membrane permeabilizing agent polymyxin B, since the 
EDTA addition alone did not sufficiently promote analyte entry into cells. This was likely 
because of the relatively high Mg
2+
 content of poultry meat (270 μg/g) compared to e.g. milk 
(150 μg/g). 
 
 
 
 
 
 
Figure 9.1. 96-well format biosensor assays developed in this study. A) Nisin bioassay. B) Tetracycline 
bioassay for tetracycline residues in poultry meat. M17G, M17 broth supplemented with 0.5% w/v 
glucose; LB, Luria-Bertani broth; PMB, polymyxin B; EDTA, ethylenediaminetetraacetic acid.   
 
A) 
 
 
 
 
B) 
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Figure 9.2. Nisin biosensor overlay assay for screening for nisin producers. The bioassay was performed 
on mixed or isolated cultures of putative nisin producers plated on agar and overlaid with a thin layer of 
soft agar seeded with NZ9800lux nisin biosensor. 
 
 
9.2 Biosensor assay performance (I, II, III) 
 
In paper I, two nisin biosensor strains, NZ9800lux and NZ9000lux, were constructed of two 
different L. lactis host strains, NZ9800 and NZ9000. The performance of NZ9800lux exceeded 
that of NZ9000lux in the speed of response, span of constant induction level, width of linear 
range, low level of background signal, and compatibility with lyophilization (Figures 1, 2, and 3 
in I). NZ9000lux did exhibit slightly better sensitivity than NZ9800lux (0.03 pg/ml vs. 0.1 
pg/ml, respectively), but the superiority of NZ9800lux in other aspects made it the prime choice 
for use in bioassays. NZ9800lux had a wider linear range and higher induction coefficients than 
NZ9000lux likely because the activity of nisin immunity proteins NisIFEG in NZ9800lux 
(Kuipers et al. 1993) protects the biosensor cell from the antimicrobial effect of nisin. NisI is 
expressed without nisin autoinduction from an internal promoter preceding the nisI gene (Li and 
O’Sullivan 2008), so the protective effect is constantly present. NZ9000lux does not harbor any 
nisin resistance genes (Kuipers et al. 1998) which would render some of the nisin unavailable for 
induction, and therefore the sensitivity is higher in this strain. 
The nisin biosensor assay was optimized for food samples using low-fat milk as a test matrix (I). 
The sensor behaved similarly in milk and in 0.1% Tween 80 pH 2.5 used as nisin standard 
diluent, but showed lower sensitivity and slower signal development due to opaqueness of milk 
(Figures 4 and 5 in I). However, diluting milk samples 1:4 in 0.1% Tween 80 pH 2.5 prior to the 
assay somewhat restored assay performance. The nisin bioassay was also applied in detecting 
nisin concentrations in culture medium samples, and simultaneously to identify a nisin-producing 
strain among three L. lactis strains (Table 1 in I). Nisin expression level was determined from 
serial dilutions of growth medium. The nisin concentration produced by strain L. lactis 20729 
after 7 h cultivation was 4.53 µg/ml in M17G broth and 0.14 µg/ml in milk, remaining constant 
until 48 h of cultivation. This experiment established the use of the bioassay in determining nisin 
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concentration in a food matrix. The difference in nisin concentration between the two culture 
media was determined to be caused by differences in stationary phase bacterial concentration: 
1.2 × 10
10
 cfu/ml in M17G medium vs. 1.2 × 10
8
 cfu/ml in milk. Also, low recoveries (25–36%) 
from spiked and diluted milk samples (= internal standardization) suggested lowered nisin 
bioavailability due to association with milk components. Measuring only the bioavailable 
fraction of the analyte is an inherent quality of whole-cell biosensors since only this soluble 
fraction can exert an inducing effect on the cell (Hansen and Sørensen 2001, van der Meer and 
Belkin 2010). It is both an advantage and disadvantage, since the bioavailable fraction is the part 
of the analyte molecule population that has the potential to have a (toxic) effect on living cells 
and organisms, but it is an underestimation of the total analyte concentration whose 
determination is often required by food safety regulations. 
The nisin biosensor assay (I) is the most sensitive nisin assay ever reported (see Table 6.1). 
Extreme sensitivity facilitates extensive dilution of the sample prior to nisin quantification, 
minimizing the effect of possible interfering factors present in the sample matrix. Simple 
pretreatment of samples under mild conditions should also protect nisin from degradation 
(Schneider et al. 2011). However, the low recovery from internal standards (I) suggests dilution 
of food samples with 0.1% Tween 80 pH 2.5 does not extract nisin sufficiently, although the 
detergent is present in the diluent to reduce nisin adsorption. It has been known for a long time 
that nisin adsorption to food components such as proteins lowers nisin bioavailability in growth 
inhibition assays, and therefore a sample pretreatment protocol (acid extraction) was devised for 
food samples (Tramer and Fowler 1964, Fowler et al. 1975). Modified versions of this protocol 
have been used in several studies including growth inhibition assays (Wolf and Gibbons 1996), 
immunoassays (Daoudi et al. 2001) and LC-MS/MS (Schneider et al. 2011). Other pretreatment 
protocols have also been developed (Rossano et al. 1998, Bouksaim et al. 1998, Soliman and 
Donkor 2010, Aly et al. 2011). In a micellar electrokinetic chromatography method for nisin 
quantification, addition of internal standard was performed after sample pretreatment, resulting 
in high recoveries (Soliman and Donkor 2010), whereas nisin addition before sample 
pretreatment led to lower recoveries (Schneider et al. 2011). Wahlström and Saris (1999) 
claimed no nisin was lost when dose-response of nisin-spiked milk samples was compared to 
nisin standards in a bioluminescent whole-cell biosensor assay. However, the limit of detection 
was higher and the linear range of the assay shifted towards higher concentrations in milk, 
suggesting lowered bioavailability. Similar results were obtained in paper I. Therefore, low 
recoveries can be present in other nisin whole-cell biosensor assays which use a similar dilution 
approach (Wahlström and Saris 1999, Reunanen and Saris 2003, Hakovirta et al. 2006). Dose-
response curves in paper I were determined using milk samples spiked to each individual 
concentration to achieve a uniform sample matrix effect, and to ensure no nisin is lost during 
dilution, so the curve should reflect real bioavailable nisin concentrations.  
Whole-cell biosensors are typically used in quantitative to semiquantitative analysis of analyte 
concentrations. The nisin biosensor was used for quantitative analysis of nisin concentrations in 
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growth medium and milk (I). The effect of bioavailability and ensuing low recoveries in milk 
samples cast a shadow of doubt on whether the results of milk sample analysis truly are 
quantitative. Recoveries were not determined for growth medium samples in paper I, so it is not 
known whether the results reflect actual nisin concentrations in the samples. Using a growth 
inhibition assay, Li and O’Sullivan (2002) have determined a maximum nisin concentration of 
2.9 μg/ml for a 10 h old culture of Lactococcus lactis subsp. lactis DSM-20729 (ATCC 11545) 
in identical culture conditions to paper I. The concentration then decreased to 1.9 μg/ml in a 48 h 
old culture. These values are similar to those determined in paper I, a maximum value of 8.58 
μg/ml at 6 h and 4.61 μg/ml at 48 h. Therefore, the recovery from growth medium samples is 
likely not as low as from milk samples, and the quantification results are more reliable. A more 
efficient extraction protocol would likely increase recovery from milk samples and facilitate 
quantification.  
There are examples of whole-cell biosensors used for quantitative detection of nisin and 
tetracycline antibiotics in food samples. The nisin bioassay developed by Reunanen and Saris 
(2003) was used for nisin quantification in sausage (Reunanen and Saris 2004). In another study, 
the tetracycline biosensor also used in paper III was utilized in determining tetracyclines in fish 
tissue (Pellinen et al. 2002). The results from the biosensor assay correlated well with HPLC 
analysis, showing whole-cell biosensors can be applied in quantitative determination of antibiotic 
residues. However, in a follow-up study of paper III, Pikkemaat et al. (2010) used the 
tetracycline biosensor assay in routine screening analysis of poultry muscle samples, and came to 
the conclusion that the assay only gave qualitative results. This was due to absorption of the 
bioluminescence signal by haemoglobin, the concentration of which varied from sample to 
sample. This could be overcome by utilizing mutant versions of bioluminescent reporter proteins 
with emission maxima not overlapping with the hemoglobin absorption spectrum. Such mutants 
of Photinus pyralis (firefly) luciferase have been created by Shapiro et al. (2005) and of GFP by 
Heim and Tsien (1996). Also, mathematical methods could be used to account for the 
bioluminescence signal lost due to haemoglobin. Another source of variation in tetracycline 
screening analysis was batch variation in ampoules of lyophilized biosensor cells. This can be 
overcome by more careful assay standardization, i.e. balancing the optical density of cells in the 
assay. 
In papers I and III, the performance of freshly cultured and lyophilized K-12(pTetLux1) and 
NZ9800lux cells was remarkably similar, facilitating reagent-like use of lyophilized biosensor 
cells in the nisin and tetracycline bioassays (Figures 4 in I and 1 in III). Similar behavior of 
cultured and lyophilized cells in a biosensor assay has previously been reported (Kurittu et al. 
2000a) and lyophilization is widely used as a preservation method for whole-cell biosensors 
(Bjerketorp et al. 2006). 
In paper III, the tetracycline bioassay at first failed to detect all four veterinary relevant 
tetracyclines (DC, doxycycline; CTC, chlortetracycline; TC, tetracycline; OTC, oxytetracycline) 
at levels below the EU maximum residue limits (MRL) (EC 1990, 1999, 2010a). Thus, a novel 
60 
 
method for whole-cell bioassay sensitization was developed using polymyxin B (PMB) and 
EDTA, two substances which cooperate to increase cell wall permeability and facilitate analyte 
entry into the biosensor cell (Figures 1 and 2 in III). The divalent cation dependent uptake 
mechanism of tetracycline into Gram negative cells is presented in Figure 9.3. In addition to 
facilitating tetracycline uptake through the cytoplasmic membrane by chelating excess Mg
2+
 ions 
(Schnappinger and Hillen 1996), EDTA chelation removes stabilizing divalent cations from the 
outer membrane (Daugelavičius et al. 2000), further aiding tetracycline entry into biosensor 
cells. PMB also removes outer membrane stabilizing cations, but its main antibiotic effect is 
forming pores in the outer membrane, and at high concentrations also in the cytoplasmic 
membrane (Daugelavičius et al. 2000). 
 
 
 
 
Figure 9.3. The divalent cation (M
2+
) dependent uptake mechanism of tetracycline into Gram negative 
cells (Schnappinger and Hillen 1996). Tetracycline is thought to pass the outer membrane of gram-
negative bacteria through the porins OmpF and OmpC chelating a M
2+
 ion as [M-tc]
+
. The cationic [M-
tc]
+
  accumulates in the periplasm. After dissociation of the [M-tc]
+
 complex the uncharged tetracycline is 
able to diffuse through the cytoplasmic membrane. In the cytoplasm the chelate must reform as only the 
chelate can bind the ribosome or TetR (Lederer et al. 1995, Aleksandrov and Simonson 2008a). 
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In the optimized assay, 0.5 µg/ml PMB was used during biosensor cell reconstitution and 
dilution prior to the assay, and a final concentration of 25 mM EDTA was dispensed to the 
microtiter plate wells with the tissue fluid samples (Tables 1 and 2 in III). In addition, the 
reconstitution medium was phosphate buffered to pH 6 to prevent the alkaline EDTA solution 
from elevating the pH above the intracellular pH, because TCs accumulate in the compartment 
with higher pH (Schnappinger and Hillen 1996). The dose-response curves of the four 
tetracyclines showed detection limits well below the MRL of 100 μg/kg set for muscle tissue 
(EC 1990, 1999, 2010a) (Figure 2 in III). Detection limits achieved in the assay were 5 µg/kg for 
DC, 7.5 µg/kg for CTC, and 25 µg/kg for TC and OTC. In other tetracycline bioassays, the limit 
of detection was 20 μg/kg for TC and slightly higher for OTC in fish muscle tissue, and 6 μg/l 
for TC, 25 μg/l for OTC, and 3 μg/l for DC and CTC in milk using the same biosensor strain 
(Kurittu et al. 2000c, Pellinen et al. 2002).  
The tetracycline biosensor assay interestingly provided proof of induction capacity and antibiotic 
effect of tetracycline 4-epimer metabolites, including 4-epidoxycycline previously thought 
ineffective (Figure 3 in III). The results were confirmed by a microbiological growth inhibition 
assay routinely used in monitoring tetracycline residues in tissue fluid samples (Pikkemaat et al. 
2008) (Figure 4 in III). The bioluminescence signal and growth inhibition was larger than would 
be inflicted by the parent compound present in the 4-epimer sample as an impurity. Also, the 
assay conditions favor epimerization instead of reversion back to parent compound (Anderson et 
al. 2005). The study on antibiotic nature of TC metabolites is of interest since 4-epidoxycycline 
was included in the provisional EU maximum residue limit list but left out from the final version 
(EC 1990, 1999, 2010a) due to assumed biological inactivity (Croubels et al. 1998a). It was also 
assumed that unlike other 4-epimers, 4-epiDC is not formed during sample preparation (EMEA 
1997). 4-epimer metabolites of the other three veterinary tetracyclines are therefore listed as 
MRL marker residues along with the parent compound (EC 2010a). However, increasing 
evidence suggests 4-epimer metabolites including 4-epiDC are also formed in vivo (Croubels et 
al. 1998b). 
In paper II, the overlay assay for screening for nisin producers showed bioluminescence 
induction in the area surrounding a nisin producing colony within 1 h of application of the sensor 
layer, but no induction around a nisin non-producer (Figure 1 in II). The assay was used for 
detection and isolation of nisin producers in mixed cultures of lactic streptococci originating 
from raw bovine milk (Figure 2A in II). However, after overnight incubation of the overlaid 
plates, growth inhibition zones were visible around colonies other than the nisin producers. 
Therefore, nisin producer screening assay specificity was verified by identifying 
bioluminescence-inducing nisin producers and otherwise antagonistic i.e. inhibition zone-
producing colonies among 144 raw milk lactic streptococcal isolates and a panel of 91 
lactococcal strains (Figure 2B in II). PCR-amplification of the nisin structural gene in a total of 
53 antagonistic isolates showed that only the bioluminescence-inducing colonies harbored the 
nisin gene. An exception to the rule was strain Lactococcus lactis subsp. lactis SL149, which 
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carried a modified nisin Z gene (Figure 3 in II). The other four lactococcal panel strains 
produced nisin A, and all seven raw milk isolates produced nisin Z (four isolates from mixed 
cultures and three colonies from lactic streptococcal isolates) (Table 1 in II and Figure 9.4). 
BOX-PCR and RAPD experiments (Supplementary Figures 1A and 1B in II) showed the genetic 
fingerprints of the seven raw milk isolates divided them in three groups, so it was not a question 
of one multi-isolate. Nisin producing raw milk isolates were identified as Lactococcus lactis 
subsp. lactis by 16S-rRNA gene sequencing and his operon amplification (Table 1 and 
Supplementary Figure 1C in II). 
Screening assay specificity was also tested with 11 strains producing reuterin or bacteriocins 
other than nisin. None of these strains induced bioluminescence, indicting nisin specificity of the 
assay (Supplementary Figure 2 in II). The antagonistic substance produced by strain SL149 was 
shown to be of lower molecular weight than nisin by SDS-PAGE and overlay nisin bioassay 
(Figure 4 in II). Based on these results and verified assay specificity, the substance in question 
was not a non-inducing nisin variant resulting from modifications in the nisin Z gene, but some 
other bacteriocin. Possible candidate bacteriocins lacticin 481, lacticin 3147 and bacteriocin J46 
were identified by a search in two bacteriocin databases, BACTIBASE (Hammami et al. 2010) 
and BAGEL2 (de Jong et al. 2010).  
 
 
 
 
 
 
Figure 9.4. Bioluminescence induction by 
nisin-producers. Nisin production in all 
eleven nisin-producing strains identified in 
paper II is indicated by bioluminescence 
production in the nisin biosensor layer 
after 1 h induction. As expected, strain 
SL149 (position C1) and nisin non-
producer NZ9000 (D3) did not induce 
bioluminescence. A1, RM-III2; A2, RM-
III1; A3, RM-II; A4, RM-I; B1, SD12; B2, 
IV-17; B3, III-32; B4, I-12; C1, SL149; 
C2, SL29; C3, SL28; C4, SD14; D3, 
NZ9000 (nisin non-producing control); 
D4, 20729 (nisin producing control). 
Unpublished data. 
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9.3 Regulatory element properties and performance (I, II, III, IV) 
 
The extremely high sensitivity of the nisin biosensor assay (I) when compared to other nisin 
detection and quantification assays (see Table 6.1) is indicative of the sophisticated ability of the 
NisRK two-component system to identify nisin and rapidly relay the response to induce 
transcription of genes under control of the nisA promoter. The bioluminescence signal from 
biosensor strains NZ9000lux and NZ9800lux was detectable in less than ten minutes from 
induction (Figure 2 in I). This response time time is extremely fast, since e.g. a DNA damage 
responsive E. coli biosensor with a recA'::luxCDABE reporter construct expressed detectable 
mitomycin-induced bioluminescence after approximately one hour (Vollmer et al. 1997), and a 
multidrug-responsive Staphylococcus aureus QacR/qca::luxCDABE biosensor after 30 min from 
benzalkonium chloride induction (Galluzzi and Karp 2007). Both host strains used in 
constructing the nisin biosensor strains harbor chromosomal nisRK genes. The chromosomal 
location of these genes was proven beneficial by Hakovirta et al. (2006) whose fluorescent nisin 
biosensor based on NZ9000 host strain was more sensitive than another biosensor strain where 
nisRK were present on the biosensor plasmid along with the promoter::reporter gene construct 
(Reunanen and Saris 2003). The same study deemed the nisA promoter stronger than PnisF, which 
ensures more efficient reporter protein expression. PnisA is also used in the NZ9000lux and 
NZ9800lux biosensor strains (I).  
Using the nisin producer screening assay, producers of nisin variants A and Z were identified, 
therefore showing the NisRK two-component regulatory protein system reacts to both variants 
(Table 1 in II and Figure 9.4). The NisRK system should respond to the other known nisin 
variants nisin F, nisin Q, nisin U and nisin U2 as well, since these variants have been shown to 
induce expression from PnisA via NisRK (Wirawan et al. 2006, Piper et al. 2011). Specificity tests 
with 11 strains producing reuterin or bacteriocins other than nisin showed no reaction to these 
substances, demonstrating the NisRK regulatory system recognizes nisin in a very specific 
manner (Supplementary Figure 2 in II). Similar results have been obtained by Wahlström and 
Saris (1999) and Kuipers et al. (1995) who reported lantibiotics such as subtilin, the structurally 
closest analog of nisin, as well as carnocin, sakacin A, lacticin 481, and Pep5, and the 
antimicrobial peptide lactococcin A do not induce transcription through the NisRK system. The 
control exerted by NisRK and PnisA was very tight, as the background expression of luxABCDE 
was only 0.02–0.05% at maximum response (I), whereas whole-cell biosensors generally display 
background expression levels of about 1–5% of the maximum response (van der Meer et al. 
2004). 
Variations in binding affinity of different tetracyclines to TetR are relayed as changes in the 
biosensor bioluminescence signal strength. The induction potency of different tetracyclines 
increased in the order OTC < TC < CTC < DC, whereas the 4-epimer metabolites had a slightly 
different order 4-epiOTC < 4-epiDC < 4-epiTC < 4-epiCTC (Figures 2 and 3 in III). All epimers 
were weaker inducers than the parent compounds. These differences reflect the variations in 
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binding affinity of the TC analogs to TetR repressor that controls bioluminescence induction. 
TetR has been determined to bind to TC and OTC with similar affinity, whereas CTC and DC 
bind TetR with higher and 4-epiTC with lower affinity (Lederer et al. 1996). Also TetR 
induction efficiency of the TC analogs varied according to binding affinity (Lederer et al. 1996), 
an effect seen in paper III as well. The background expression level in the tetracycline biosensor 
was 2–4% of maximum, which is a typical value for whole-cell biosensors (van der Meer et al. 
2004).  
In paper IV, DNA affinity affecting mutations were rationally designed in the erythromycin 
specific repressor MphR(E) based on a homology model  (Figure 2 in IV) built using the crystal 
structure of a related repressor MphR(A) (Zheng et al. 2009) as a reference. Structure-function 
studies of MphR(E) and its mutants showed variations in DNA binding affinity (Table 1 and 
Figure 4 in IV). Among the seven rationally designed mutants studied, there were three with 
increased (K, KC and CG), one with similar (Y) and three with decreased (H, N, L) affinity to 
operator DNA. However, mutation T35K alone can likely be accredited with producing the 
improved affinity of double mutant KC, as the affinity of these two mutants was similar. Mutants 
K, KC and CG showed approximately an 1.3-fold improvement in DNA binding affinity when 
compared to wild type MphR(E) which bound operator DNA with a dissociation constant Kd of 
289 ± 20 nM. MphR(E) bound its operator DNA with a higher affinity than the related  repressor 
MphR(A) (Kd of 574 ± 29 nM) (Zheng et al. 2009) but with a much lower affinity than TetR (Kd 
of 0.2 nM) (Kamionka et al. 2006). Despite of the relatively low affinity towards operator DNA, 
MphR(A) has been successfully used as the recognition element in an E. coli whole-cell 
biosensor responsive to macrolides (Möhrle et al. 2007). However, in addition to inserting the 
entire mphA operon (Figure 1 in IV) in the host strain chromosome, an extrachromosomal vector 
for overexpression of MphR(A) had to be included in the biosensor strain for sufficient 
repression of luxCDABE expression. 
In addition to improved DNA affinity, mutant CG was observed to form a covalent dimer 
through disulfide formation (Table 1 and Supplementary Figure S2 in IV). This result was 
interesting, since in the homology model of MphR(E), the cysteine residues forming the disulfide 
bond are approximately 20 Å apart, and should therefore not be able to interact. This indicates 
that the in vivo structure of MphR(E) deviates from the model. However, the mutations designed 
to affect DNA binding did cause affinity changes and there is significant sequence conservation 
between the DNA binding helix-turn-helix motifs of MphR(E) and MphR(A) (Figure 3 in IV) 
(Szczepanowski et al. 2007, Zheng et al. 2009), so the model is likely to reflect in vivo structure 
of MphR(E) in these regions. However, the KC double mutant designed to exhibit the affinity 
improving effect of mutation T35K as well as to form an intermonomeric disulfide bond did not 
dimerize covalently. Instead, native mass spectrometry showed mutants K and KC form 
noncovalent dimers (Figure 7 in IV). The homology model placed the L182C mutation site in the 
dimerization interface between the two monomers, but because a disulphide was not observed in 
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the experiments, it is possible the homology model is not able to predict the protein fold 
correctly in this region.  
Ligand binding properties of MphR(E) were also studied in paper IV. The repressor protein did 
not bind lincosamide ligands lincomycin and clindamycin or 16-membered macrolides tylosin 
and spiramycin. Instead. MphR(E) bound 14-membered macrolides erythromycin, 
oleandomycin, and clarithromycin (Figures 5, 6 and 8 in IV). Szczepanowski et al. (2007) show 
the mph(E) operon (Figure 1 in IV) gives resistance to 14-membered erythromycin and 
roxithromycin as well as to 15-membered azithromycin, so MphR(E) is likely to be induced by 
this ring structure as well. Conversely, the mph(E) operon gave very weak resistance to tylosin 
which is likely due to leaky expression of resistance genes without MphR(E) induction. Table 
9.1 presents the ligand binding spectrum of MphR(A). It is wider than the spectrum of MphR(E), 
with effective binding of 12- to 16-membered  macrolides. Binding of MphR(E) to 12-membered 
macrolides has not been studied. The EU MRL values have been set for four 16-membered, two 
15-membered, and one 14-membered macrolide (EC 1990, 1999, 2010a). Therefore, if used as a 
biosensor recognition element, MphR(E) cannot respond to all relevant macrolides. Instead, it 
can be used to distinguish between ligands with varying ring structures. 
Mutants K, KC and CG all bound erythromycin but with slightly (K and KC) or significantly 
(CG) lower affinity than wild type MphR(E) (Table 1 and figures 6-7 in IV). It was not 
surprising that covalent dimerization of CG would affect ligand binding properties as well, but 
the adverse effect of the DNA binding domain mutation T35K was less expected. Mutation 
L182C, however, did not affect ligand binding even though it was located in the ligand binding 
domain. A study of disulfide bonds designed in the TetR structure showed that intermonomeric 
disulfides can be rationally designed in the dimer without adversely affecting DNA binding or 
Table 9.1. Ligand binding spectrum of MphR(A). 
Macrolide Lactone ring 
members 
MphR(A) 
binding 
Ref. Macrolide Lactone ring 
members 
MphR(A) 
binding 
Ref. 
Azithromycin 15 + [1] Kitasamycin 16 + [4] 
  ++ [2] Methymycin 12 +++ [3] 
  ++ [3] Narbomycin 14 + [3] 
Clarithromycin 14 +++ [1] Oleandomycin 14 +++ [1] 
  +++ [2]   ++ [2] 
  ++ [3]   ++++ [3] 
Erythromycin 14 ++++ [1]   +++ [4] 
  +++ [2] Picromycin 14 + [3] 
  +++ [3] Roxithromycin 14 ++ [1] 
  +++ [4]   ++ [2] 
Josamycin 16 + [4] Tylosin 16 ++ [2] 
[1] Weber et al. 2004; [2] Link et al. 2007;[3] Möhrle et al. 2007; [4] Noguchi et al. 2000. 
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inducibility (Tiebel et al. 1998). However, ligand binding affinity of TetR was improved by 
some intermonomeric disulfides and weakened by some. Fluorescence anisotropy experiments 
(Figure 5 in IV) showed that CG was the only mutant with weakened inducibility: not even 25-
fold molar excess of erythromycin was enough for complete dissociation from operator DNA. 
The other mutants had an inducibility similar to wild type MphR(E). Disulfide bond formation 
over such a long distance (20 Å as indicated by the homology model) may distort repressor 
structure more than intermonomeric bonding occurring over a shorter distance (6–8 Å) in TetR 
(Tiebel et al. 1998). 
In the crystal structure of MphR(A), a chloride ion was located in close proximity to the ligand 
binding site (Zheng et al. 2009). Therefore, the effect of chloride ion on ligand binding by 
MphR(E) was determined (Figure 6d in IV). The chloride ion did not bind MphR(E) and no 
changes in the ligand binding interaction were seen, so it seems to have no part in MphR(E) 
function. In TetR, the Mg
2+
 ion of the TC-Mg complex is primarily responsible for the structural 
change required for induction (Orth et al. 1999). A new mode of negative allosteric modulation 
of ligand binding was suggested by the mass spectrometry results (Figures 6-7 in IV), as the 
abundance of the two-ligand complex was lower than expected if the Kd values were the same for 
the two binding sites. Fluorescence anisotropy results indicated both ligand binding sites must be 
occupied for full induction of MphR(E) (Figure 5 in IV). This is consistent with results from 
TetR (Orth et al. 1999, Kamionka et al. 2006). The majority of TFRs bind two ligands per dimer, 
but some only one. A single molecule of a bulky ligand can cause the structural change required 
for induction, but two molecules of smaller ligands are required (Itou et al. 2010). 
Pathogenic origin of a protein may cause doubts about whether it is suitable for use in e.g. 
biosensor applications. MphR(E) gene harboring plasmid pRSB111 was isolated in wastewater, 
and therefore the host organism is not known (Szczepanowski et al. 2007). Plasmid pRSB111 is 
a member of the incompatibility group IncP-1, which consists of broad host-range conjugative 
plasmids that are deemed potent vehicles for the spread of antibiotic resistance within and 
between bacterial communities (Schlüter et al. 2007). Plasmid pRSB111 is closely related to 
prototype IncP-1β plasmid pB3, whose plasmid-host history suggests its ancestry consists of two 
putative hosts: Ralstonia solanacearum, a phytopathogen, and Eggerthella lenta, a gut 
commensal which rarely causes infection (Norberg et al. 2011). The result was based on 
genomic signature analysis of conserved backbone regions descending from parental plasmids, 
which have evolved in different hosts. Therefore, MphR(E) is not of human pathogen origin. 
Like all Inc-P1 plasmids, pRSB111 is self-transmissible, and efficient transfer from Escherichia 
coli to Escherichia coli, Pseudomonas sp. and Ralstonia eutropha has been shown 
(Szczepanowski et al. 2007). 
MphR(E) mutants with improved DNA affinity can benefit whole-cell biosensor design, as 
higher DNA affinity can be expected to lead to more efficient repression of the reporter gene and 
lowered background signal values. Mutant K also showed ligand binding and induction 
properties almost similar to wild type MphR(E) (IV). In contrast, mutant CG showed improved 
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DNA affinity but impaired ligand binding and induction. In a whole-cell biosensor setting, this 
would likely result in tightened repression but also induction at higher macrolide concentrations, 
i.e. lower sensitivity. However, the use of mutant CG as the recognition element might lead to a 
wider assay dynamic range as dissociation from DNA occurs on a wider range of macrolide 
concentrations than normal. TetR mutants with enhanced DNA affinity were characterized by 
repression of β-galactosidase activity in a whole-cell biosensor (Helbl and Hillen 1998, Helbl et 
al. 1998). Therefore, enhanced transcriptional control by the TetR mutants was verified in an in 
vivo gene regulatory circuit. This remains to elucidated for MphR(E) mutants. It is not self-
evident that regulatory proteins with enhanced function improve biosensor functioning: mutants 
of the DmpR regulatory protein with enhanced ligand binding did not functionalize into elevated 
transcription initiation (Skärfstad et al. 2000). 
 
 
9.4 Applicability of biosensor assays in screening (I, II, III) 
 
The functionality of the nisin bioassay as a screening test was first shown by identifying a nisin-
producing strain among three L. lactis strains (I). Since it is laborious to perform screening 
through a full bioassay with culture medium dilutions as samples, a simple nisin producer 
screening assay in plate overlay format was developed (II). The bioluminescence induction 
surrounding a nisin-producing colony is detected directly from the plate without a separate assay, 
and results are obtained very rapidly, within one hour. High-throughput capacity of the screening 
overlay assay was increased by employing a plate divided in a grid of thirty-six 2 cm x 2 cm 
squares, on which inoculations of isolated cultures were made. In paper II, the specificity of the 
screening assay for nisin was also confirmed, further corroborating its reliability. The PCR 
methods used for nisin producer identification falsely recognized one strain as a nisin producer, 
but the nisin screening assay and confirmatory studies verified the strain as a nisin non-producer 
that harbors a non-functional nisin structural gene giving a positive PCR result. Presence of 
nonfunctional nisin genes has been shown previously (Moschetti et al. 1996, Vuyst 1994). The 
phenomenon can be due to dysfunction or absence of the nisin biosynthesis operon genes or 
proteins since production of nisin is a concerted action of a number of gene products (Lubelski et 
al. 2008). Unlike growth inhibition assays, the overlay assay directly identifies the antimicrobial 
in question is indeed nisin, and avoids the PCR-based method pitfall related to nonfunctional 
nisin genes. The overlay assay is expected to be responsive to all known natural nisin variants, 
but it cannot identify the nisin variant in question. Therefore, a confirmatory method such as the 
LC-MS method by Zendo et al. (2007) could be employed for variant identification. 
Since inducible whole-cell biosensor response to analytes is typically group-specific and depends 
on potency of the inducer, it is generally not possible to identify the analyte. However, 
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Smolander et al. (2009) have developed an algorithm which allows direct identification of β-
lactams inducing bioluminescence in a compound-specific biosensor. By following response 
trajectories over 300 minutes, it was possible to differentiate between 15 β-lactams. The 
classification system is scalable to larger sets of antibiotics of the same class, or antibiotics of 
other classes than β-lactams. This kind of an approach has potential in screening for new 
antibiotics and identification of antibiotic residues. It could be employed in direct identification 
of nisin variants (II) or tetracyclines (III) causing induction in the screening assays. 
Nisin and tetracycline biosensors were readily lyophilized for reagent-like use in the assay, and 
performed similarly to freshly cultured cells (I, III). In paper II, freshly cultured NZ9800lux 
cells were used in the assay, but there is no impediment to using lyophilized cells in the overlay. 
Both nisin and tetracycline biosensors express inherent bioluminescence without the addition of 
exogenous substrates. This further simplifies their use in screening. The nisin biosensor was 
detected to maintain a constant induction level for several hours (Figure 1 in I), which adds to its 
applicability in screening. Unlike growth inhibition methods, whole-cell biosensor assays are 
suitable for assay miniaturization (van der Meer 2004). A plate assay format is as an essential 
prerequisite for a rapid, inexpensive high-throughput screening system.  
In a follow-up study of paper III, Pikkemaat et al. (2010) used the tetracycline biosensor assay in 
routine screening analysis of poultry muscle samples. The method was determined to be specific 
and robust. It correctly identified noncompliant samples, but indicated more suspect samples 
than a microbial inhibition test. This can be avoided by adjusting the cut-off value selected for 
differentiating between suspect and compliant samples. The whole-cell biosensor assay was 
faster, more sensitive and more cost-effective than the microbiological assay. Market price per 
sample was 15 € with the microbiological and 7.5 € with the biosensor assay.  
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10 CONCLUSIONS   
 
Whole-cell biosensors are a valid alternative in development of antibiotic detection and 
screening methods. The tetracycline and nisin assays developed in this study (I, II, III) are 
simple and rapid to perform, have good high-throughput capacity, and need minimum sample 
pretreatment and no exogenous substrate additions. These methods show potential in replacing 
the less specific and sensitive, very laborious and voluminous microbial growth inhibition assays 
used in screening for antibiotic residues and nisin producers as well as nisin quantification. The 
biosensor bacteria are compatible with lyophilization, facilitating ready availability and reagent-
like use.  
The nisin assay (I) shows extremely high sensitivity towards it analyte due to the strict control 
and efficient transcription activation by the NisRK two-component regulatory system and nisA 
promoter. It is the most sensitive nisin detection method ever published. Of the two nisin 
biosensor strains, the performance of NZ9800lux exceeded that of NZ9000lux in most aspects. 
Most importantly, NZ9800lux showed a wider linear range and higher induction coefficients due 
to a lower background signal. NZ9000lux did have higher sensitivity towards nisin due to the 
absence of nisin immunity proteins, but the difference to NZ98000lux was negligible.  
The nisin bioassay (I) can be used for quantitative determination of nisin concentrations in 
simple sample matrices such as growth medium. However, low recoveries from milk suggest a 
more efficient nisin extraction protocol is needed for complex sample matrices. 
The nisin biosensor strain was successfully used in screening for nisin producers in raw milk and 
among a panel of lactococcal strains (II). The assay could identify nisinogenic bacteria in mixed 
cultures after a simple plating and overlay protocol. Four nisin A producers were identified 
among the lactococcal panel strains, and seven nisin Z producers in raw milk. The seven nisin Z 
producers were not a multi-isolate, as they divided in three groups by genetic fingerprinting. 
The screening assay proved very specific for nisin, as other bacteriocins and substances produced 
by antagonistic bacteria did not induce bioluminescence (II). The results were verified by PCR 
amplification which showed only strains harboring the nisin structural gene induced 
bioluminescence. An exception was a strain that was antagonistic and harbored a modified nisin 
gene but did not induce bioluminescence. With additional experiments, this strain was confirmed 
to produce a bacteriocin of lower molecular weight than nisin, and not a non-inducing variant of 
nisin.  
A whole-cell biosensor assay for tetracycline residues in poultry muscle tissue was developed in 
paper III. An assay sensitization method was developed to lower the detection limit of all 
veterinary relevant tetracyclines to below-MRL concentrations. Sensitization was performed 
using membrane permeabilizing and chelating agents polymyxin B and EDTA. Together these 
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facilitate analyte entry into the biosensor cell and promote tetracycline accumulation into the 
intracellular compartment. 
Veterinary tetracycline 4-epimer metabolites were shown (III) to harbor induction capacity of 
the tetracycline biosensor as well as antimicrobial activity which has previously been thought 
absent for 4-epidoxycycline. Therefore, the inclusion of this metabolite as a marker residue for 
doxycycline MRLs should be reconsidered.  
The tetracycline biosensor assay showed acharacteristic induction potency for each tetracycline 
antibiotic and 4-epimer tested. These differences reflect variations in the binding affinity of each  
substance to the recognition element TetR. 
This study included the first ever structure-function study of the macrolide-specific repressor 
protein MphR(E) (IV). DNA affinity affecting mutations were rationally designed on basis of a 
homology model of MphR(E). Of the seven designed mutants, three (K, KC and CG) showed 
improved affinity, one similar, and three decreased affinity towards operator DNA as compared 
to wild type MphR(E). One source of affinity improvement was the T35K mutation present in 
two mutants. The third mutant CG unexpectedly showed covalent dimerization which was 
accredited for improved affinity.  
The ligand binding spectrum of MphR(E) covered macrolides with a 14-membered lactone ring 
structure, but not lincosamides or 16-membered ring macrolides (IV). MphR(E) mutants K and 
KC showed slightly impaired ligand binding properties, but induction i.e. dissociation from 
operator DNA occurred with similar efficiency as wild type MphR(E). However, mutant CG had 
significantly impaired ligand binding properties and induction capability. Covalent dimerization 
is likely to cause structural changes that affect the ligand binding site and allosteric regulation of 
DNA binding.  
The ligand binding experiments suggested a novel type of negative allosteric modulation of 
ligand binding among TetR family of transcriptional regulators (IV). Chloride ions had no effect 
on ligand binding by MphR(E). However, both ligand binding sites in the homodimer must be 
occupied for induction. 
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11 RECOMMENDATIONS FOR FURTHER STUDY 
 
MphR(E) mutants designed in this study (paper IV) can benefit macrolide specific (whole-cell) 
biosensor design as higher operator DNA affinity can result in more efficient regulation. 
However, their functionality in an in vivo gene regulatory circuit will not necessarily reflect the 
effects seen in vitro and needs to be determined. The biosensor design can be a whole-cell, or the 
repressor-protein interaction can be used as the biosensing system without the surrounding cell. 
Such biosensor systems have previously been constructed for tetracyclines (Pellinen et al. 2006) 
and tetracyclines, macrolides and streptogramins (Weber et al. 2005). They are based on 
immobilizing the operator DNA in a well, and allowing the DNA binding reaction of the 
repressor protein to occur in the presence of varying amounts of the antibiotic analyte. After 
removing antibiotic-bound repressor from the well by washing, the DNA-bound repressor 
remaining in the well is quantified. Antibiotic concentration can then be derived from the result.  
MphR(E) is one example of an antibiotic specific regulator that has not been utilized in biosensor 
designs. Regulatory systems specific for one antibiotic group are relatively rare, but necessary in 
inducible compound-specific biosensor development. When bacteria are treated with sublethal 
concentrations of antibiotics, they alter global transcription patterns by repressing or activating 
expression. For example, in Salmonella typhimurium, as many as 5% of promoters may be 
affected (Goh et al. 2002). Through these kinds of experiments, new regulator-operator pairs 
could be identified for biosensing applications. Also, known regulatory proteins can be modified 
for altered ligand specificity to include or exclude certain molecules in the ligand spectrum 
(Scholz et al. 2003, Hakkila et al. 2011)  
 A multiplate approach is used in microbial growth inhibition assays for simultaneous 
identification of several compound groups and preliminary classification of the inhibiting 
antibiotic residue (Pikkemaat et al. 2008, 2009a, 2011, Gaudin et al. 2010). A similar approach 
could be used with inducible whole-cell biosensors. Since a compound-specific biosensor does 
not exist for each antibiotic group, a panel of biosensor bacteria responsive to various antibiotic 
groups through stress reactions and compound-specific reactions would help in classifying the 
residue conclusively. Such an approach has been introduced for selected classes of toxic 
compounds (Belkin et al. 1997), and also for antibiotics (Bianchi and Baneyx 1999, Shapiro and 
Baneyx 2002, 2007, Hutter et al. 2004a, Urban et al. 2007), but these biosensor panels are not 
able to conclusively classify the residue. Therefore, compound specific biosensors could be 
incorporated for more accurate classification. A recent study by Melamed et al. (2012) combined 
a panel of antibiotic-inducible effect-specific whole-cell biosensors and an algorithm-based 
approach to compute patterns of response by various antibiotics to derive the identity of the 
inducing antibiotic. This kind of an approach can reduce the need for compound-specificity. 
Im paper II, the Lactococcus lactis subsp. lactis strain SL149 was shown to harbor a modified 
nisin Z gene, and to produce a bacteriocin-like antagonistic substance with a lower molecular 
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mass than nisin. It would be of interest to find out the reason behind hampered expression of the 
modified nisin Z gene by PCR amplification and sequencing of the nisin biosynthesis operon to 
see if the operon is intact. Also, the expression of the modified nisin Z should be verified by 
mutating a functional nisin structural gene, and the resulting gene product tested for NisRK 
induction and antimicrobial activity. The nisin producer screening assay could also be applied in 
e.g. monitoring population dynamics of nisin producers used as protective starter cultures in 
production of fermented foods. It was also suggested in paper II that biosensors responsive to 
other bacteriocins could be constructed by utilizing auto-inducible regulation of their 
biosynthetic gene clusters. Such a biosensor already exists for subtilin, the structurally closest 
homolog of nisin (Burkard et al. 2007).  
The assay sensitization method developed in paper III could be utilized as a universal method to 
facilitate analyte entry into whole-cell biosensors. The sensitization method can in principle be 
adjusted for any analyte and host cell by the right choice of permeabilizing and chelating agent 
concentrations and activities. Polymyxin B is effective against Gram negative bacteria 
(Daugelavičius et al. 2000), but permeabilizing antibiotics effective towards Gram positives are 
known, such as gramicidin S (Kondelewski et al. 1996). It would be of interest to test various 
sensitization methods on various host organisms and analytes. 
The nisin bioassay (I) showed low analyte recoveries from complex food matrices. Development 
of a more efficient extraction protocol is therefore necessary. Generally good results have been 
obtained with nisin extraction protocols based on acid extraction, since unlike most proteins, 
nisin is highly soluble at pH 2 (Cleveland et al. 2001). At low pH, nisin can even withstand 
heating to 121 °C without losing its activity (Noonpakdee et al. 2003). A combination of acidic 
pH and heating should remove most of the assay interfering molecules with which nisin 
interacts. Nisin shows interaction with both food proteins and fats (Aasen et al. 2003), so 
separating nisin from lipids should be taken into consideration when designing the extraction 
protocol. The extraction protocol should be validated for various food matrices in which nisin is 
typically used as a preservative and/or nisin producers are present. 
A follow-up study of paper III comparing the tetracycline whole-cell biosensor assay with 
microbiological inhibition assays and LC-MS/MS detection of tetracyclines has confirmed the 
value and applicability of the biosensor approach in routine analyses of poultry muscle samples 
(Pikkemaat et al. 2010). In the future, validation for use in routine analysis of samples from other 
food-producing species and tissues listed in the EU MRLs (EC 2010b) should be performed. 
Validation should be performed according to European Commission Decision 2002/657/EC (EC 
2002b) and following the guideline document by EU Reference Laboratories which describes in 
detail screening method validation through determination of stability, applicability and 
ruggedness, as well as selectivity and specificity (Anon 2010). In this way, whole-cell biosensors 
could gain a foothold among screening methods available for antibiotic residue analysis. 
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